הבדלים בין גרסאות בדף "קוד ATC code - ATC"
מתוך ויקירפואה
שורה 4,433: | שורה 4,433: | ||
|A11GB01 | |A11GB01 | ||
|[[Ascorbic acid (vitamin C) and calcium]] | |[[Ascorbic acid (vitamin C) and calcium]] | ||
− | |||
|- | |- | ||
| | | | ||
שורה 4,447: | שורה 4,446: | ||
|A11HA | |A11HA | ||
| | | | ||
− | |[[Other plain vitamin preparations A11HA01 Nicotinamide]] | + | |[[Other plain vitamin preparations]] |
+ | | | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |A11HA01 | ||
+ | |[[Nicotinamide]] | ||
|- | |- | ||
| | | | ||
שורה 23,926: | שורה 23,933: | ||
| | | | ||
|L01XC04 | |L01XC04 | ||
− | |[[Alemtuzumab]] | + | |[[Alemtuzumab]] (בוטל) |
|- | |- | ||
| | | | ||
שורה 23,994: | שורה 24,001: | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |L01XC14 |
+ | |[[trastuzumab emtansine]] | ||
|- | |- | ||
| | | | ||
שורה 24,002: | שורה 24,009: | ||
| | | | ||
| | | | ||
− | | | + | |L01XC15 |
− | |[[ | + | |[[obinutuzumab]] |
|- | |- | ||
| | | | ||
שורה 24,009: | שורה 24,016: | ||
| | | | ||
| | | | ||
− | | | + | |L01XC16 |
− | |[[ | + | |[[dinutuximab beta]] |
|- | |- | ||
| | | | ||
שורה 24,016: | שורה 24,023: | ||
| | | | ||
| | | | ||
− | | | + | |L01XC17 |
− | |[[ | + | |[[nivolumab]] |
|- | |- | ||
| | | | ||
שורה 24,023: | שורה 24,030: | ||
| | | | ||
| | | | ||
− | | | + | |L01XC18 |
− | |[[ | + | |[[pembrolizumab]] |
|- | |- | ||
| | | | ||
שורה 24,030: | שורה 24,037: | ||
| | | | ||
| | | | ||
− | | | + | |L01XC19 |
− | |[[ | + | |[[blinatumomab]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |L01XC21 |
+ | |[[ramucirumab]] | ||
|- | |- | ||
| | | | ||
שורה 24,044: | שורה 24,051: | ||
| | | | ||
| | | | ||
− | | | + | |L01XC22 |
− | |[[ | + | |[[necitumumab]] |
|- | |- | ||
| | | | ||
שורה 24,051: | שורה 24,058: | ||
| | | | ||
| | | | ||
− | | | + | |L01XC23 |
− | |[[ | + | |[[elotuzumab]] |
|- | |- | ||
| | | | ||
שורה 24,058: | שורה 24,065: | ||
| | | | ||
| | | | ||
− | | | + | |L01XC24 |
− | |[[ | + | |[[daratumumab]] |
|- | |- | ||
| | | | ||
שורה 24,065: | שורה 24,072: | ||
| | | | ||
| | | | ||
− | | | + | |L01XC25 |
− | |[[ | + | |[[mogamulizumab]] |
|- | |- | ||
| | | | ||
שורה 24,072: | שורה 24,079: | ||
| | | | ||
| | | | ||
− | | | + | |L01XC26 |
− | |[[ | + | |[[inotuzumab ozogamicin]] |
|- | |- | ||
| | | | ||
שורה 24,079: | שורה 24,086: | ||
| | | | ||
| | | | ||
− | | | + | |L01XC27 |
− | |[[ | + | |[[olaratumab]] |
|- | |- | ||
| | | | ||
שורה 24,086: | שורה 24,093: | ||
| | | | ||
| | | | ||
− | | | + | |L01XC28 |
− | |[[ | + | |[[durvalumab ]] |
|- | |- | ||
| | | | ||
שורה 24,093: | שורה 24,100: | ||
| | | | ||
| | | | ||
− | | | + | |L01XC29 |
− | |[[ | + | |[[bermekimab]] |
|- | |- | ||
| | | | ||
שורה 24,100: | שורה 24,107: | ||
| | | | ||
| | | | ||
− | | | + | |L01XC31 |
− | |[[ | + | |[[avelumab]] |
|- | |- | ||
| | | | ||
שורה 24,107: | שורה 24,114: | ||
| | | | ||
| | | | ||
− | | | + | |L01XC32 |
− | |[[ | + | |[[atezolizumab]] |
|- | |- | ||
| | | | ||
שורה 24,114: | שורה 24,121: | ||
| | | | ||
| | | | ||
− | | | + | |L01XC33 |
− | |[[ | + | |[[cemiplimab]] |
|- | |- | ||
| | | | ||
שורה 24,121: | שורה 24,128: | ||
| | | | ||
| | | | ||
− | | | + | |L01XC34 |
− | |[[ | + | |[[moxetumomab pasudotox]] |
|- | |- | ||
| | | | ||
שורה 24,128: | שורה 24,135: | ||
| | | | ||
| | | | ||
− | | | + | |L01XC35 |
− | |[[ | + | |[[tafasitamab]] |
|- | |- | ||
| | | | ||
שורה 24,135: | שורה 24,142: | ||
| | | | ||
| | | | ||
− | | | + | |L01XC36 |
− | |[[ | + | |[[enfortumab vedotin]] |
|- | |- | ||
| | | | ||
שורה 24,142: | שורה 24,149: | ||
| | | | ||
| | | | ||
− | | | + | |L01XC37 |
− | |[[ | + | |[[polatuzumab vedotin]] |
|- | |- | ||
| | | | ||
שורה 24,149: | שורה 24,156: | ||
| | | | ||
| | | | ||
− | | | + | |L01XC38 |
− | |[[ | + | |[[isatuximab]] |
|- | |- | ||
| | | | ||
שורה 24,156: | שורה 24,163: | ||
| | | | ||
| | | | ||
− | | | + | |L01XC39 |
− | |[[ | + | |[[belantamab mafodotin]] |
|- | |- | ||
| | | | ||
שורה 24,163: | שורה 24,170: | ||
| | | | ||
| | | | ||
− | | | + | |L01XC40 |
− | |[[ | + | |[[dostarlimab]] |
|- | |- | ||
| | | | ||
שורה 24,170: | שורה 24,177: | ||
| | | | ||
| | | | ||
− | | | + | |L01XC41 |
− | |[[ | + | |[[trastuzumab deruxtecan]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |L01XD | ||
| | | | ||
− | + | |[[Sensitizers used in photodynamic/radiation therapy]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 24,184: | שורה 24,191: | ||
| | | | ||
| | | | ||
− | | | + | |L01XD01 |
− | |[[ | + | |[[Porfimer sodium]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |L01XD03 |
+ | |[[Methyl aminolevulinate]] | ||
|- | |- | ||
| | | | ||
שורה 24,198: | שורה 24,205: | ||
| | | | ||
| | | | ||
− | | | + | |L01XD04 |
− | |[[ | + | |[[Aminolevulinic acid]] |
|- | |- | ||
| | | | ||
שורה 24,205: | שורה 24,212: | ||
| | | | ||
| | | | ||
− | | | + | |L01XD05 |
− | |[[ | + | |[[Temoporfin]] |
|- | |- | ||
| | | | ||
שורה 24,212: | שורה 24,219: | ||
| | | | ||
| | | | ||
− | | | + | |L01XD06 |
− | |[[ | + | |[[Efaproxiral]] |
|- | |- | ||
| | | | ||
שורה 24,219: | שורה 24,226: | ||
| | | | ||
| | | | ||
− | | | + | |L01XD07 |
− | |[[ | + | |[[padeliporfin]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |L01XE | ||
| | | | ||
− | + | |[[Protein kinase inhibitors]] (בוטל) | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 24,233: | שורה 24,240: | ||
| | | | ||
| | | | ||
− | | | + | |L01XE01 |
− | |[[ | + | |[[Imatinib]](בוטל) |
|- | |- | ||
| | | | ||
שורה 24,240: | שורה 24,247: | ||
| | | | ||
| | | | ||
− | | | + | |L01XE02 |
− | |[[ | + | |[[Gefitinib]](בוטל) |
|- | |- | ||
| | | | ||
שורה 24,247: | שורה 24,254: | ||
| | | | ||
| | | | ||
− | | | + | |L01XE03 |
− | |[[ | + | |[[Erlotinib]](בוטל) |
|- | |- | ||
| | | | ||
שורה 24,254: | שורה 24,261: | ||
| | | | ||
| | | | ||
− | | | + | |L01XE04 |
− | |[[ | + | |[[Sunitinib]](בוטל) |
|- | |- | ||
| | | | ||
שורה 24,261: | שורה 24,268: | ||
| | | | ||
| | | | ||
− | | | + | |L01XE05 |
− | |[[ | + | |[[Sorafenib]](בוטל) |
|- | |- | ||
| | | | ||
שורה 24,268: | שורה 24,275: | ||
| | | | ||
| | | | ||
− | | | + | |L01XE06 |
− | |[[ | + | |[[Dasatinib]](בוטל) |
|- | |- | ||
| | | | ||
שורה 24,275: | שורה 24,282: | ||
| | | | ||
| | | | ||
− | | | + | |L01XE07 |
− | |[[ | + | |[[Lapatinib]](בוטל) |
|- | |- | ||
| | | | ||
שורה 24,282: | שורה 24,289: | ||
| | | | ||
| | | | ||
− | | | + | |L01XE08 |
− | |[[ | + | |[[Nilotinib]](בוטל) |
|- | |- | ||
| | | | ||
שורה 24,289: | שורה 24,296: | ||
| | | | ||
| | | | ||
− | | | + | |L01XE09 |
− | |[[ | + | |[[Temsirolimus]](בוטל) |
|- | |- | ||
| | | | ||
שורה 24,296: | שורה 24,303: | ||
| | | | ||
| | | | ||
− | | | + | |L01XE10 |
− | |[[ | + | |[[Everolimus]](בוטל) |
|- | |- | ||
| | | | ||
שורה 24,303: | שורה 24,310: | ||
| | | | ||
| | | | ||
− | | | + | |L01XE11 |
− | |[[ | + | |[[Pazopanib]](בוטל) |
|- | |- | ||
| | | | ||
שורה 24,310: | שורה 24,317: | ||
| | | | ||
| | | | ||
− | | | + | |L01XE12 |
− | |[[ | + | |[[Vandetanib]](בוטל) |
|- | |- | ||
| | | | ||
שורה 24,317: | שורה 24,324: | ||
| | | | ||
| | | | ||
− | | | + | |L01XE13 |
− | |[[ | + | |[[Afatinib]](בוטל) |
|- | |- | ||
| | | | ||
שורה 24,324: | שורה 24,331: | ||
| | | | ||
| | | | ||
− | | | + | |L01XE14 |
− | |[[ | + | |[[Bosutinib]](בוטל) |
|- | |- | ||
| | | | ||
שורה 24,331: | שורה 24,338: | ||
| | | | ||
| | | | ||
− | | | + | |L01XE15 |
− | |[[ | + | |[[Vemurafenib]](בוטל) |
|- | |- | ||
| | | | ||
שורה 24,338: | שורה 24,345: | ||
| | | | ||
| | | | ||
− | | | + | |L01XE16 |
− | |[[ | + | |[[Crizotinib]](בוטל) |
|- | |- | ||
| | | | ||
שורה 24,345: | שורה 24,352: | ||
| | | | ||
| | | | ||
− | | | + | |L01XE17 |
− | |[[ | + | |[[Axitinib]](בוטל) |
|- | |- | ||
| | | | ||
שורה 24,352: | שורה 24,359: | ||
| | | | ||
| | | | ||
− | | | + | |L01XE18 |
− | |[[ | + | |[[Ruxolitinib]](בוטל) |
|- | |- | ||
| | | | ||
שורה 24,359: | שורה 24,366: | ||
| | | | ||
| | | | ||
− | | | + | |L01XE19 |
− | |[[ | + | |[[Ridaforolimus]](בוטל) |
|- | |- | ||
| | | | ||
שורה 24,366: | שורה 24,373: | ||
| | | | ||
| | | | ||
− | | | + | |L01XE21 |
− | |[[ | + | |[[Regorafenib]](בוטל) |
|- | |- | ||
| | | | ||
שורה 24,373: | שורה 24,380: | ||
| | | | ||
| | | | ||
− | | | + | |L01XE22 |
− | |[[ | + | |[[Masitinib]](בוטל) |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |L01XF | ||
| | | | ||
− | + | |[[Retinoids for cancer treatment]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 24,387: | שורה 24,394: | ||
| | | | ||
| | | | ||
− | | | + | |L01XF01 |
− | |[[ | + | |[[tretinoin]] |
|- | |- | ||
| | | | ||
שורה 24,394: | שורה 24,401: | ||
| | | | ||
| | | | ||
− | | | + | |L01XF02 |
− | |[[ | + | |[[alitretinoin]] |
|- | |- | ||
| | | | ||
שורה 24,401: | שורה 24,408: | ||
| | | | ||
| | | | ||
− | | | + | |L01XF03 |
− | |[[ | + | |[[bexarotene]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |L01XG | ||
| | | | ||
− | + | |[[Proteasome inhibitors]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | | | + | |L01XG01 |
− | [[ | + | |[[bortezomib]] |
|- | |- | ||
| | | | ||
שורה 24,423: | שורה 24,429: | ||
| | | | ||
| | | | ||
− | | | + | |L01XG02 |
− | | | + | |[[carfilzomib]] |
|- | |- | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
| | | | ||
− | |[[ | + | |L01XG03 |
+ | |[[ixazomib]] | ||
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
+ | |L01XH | ||
| | | | ||
− | |[[ | + | |[[Histone deacetylase (HDAC) inhibitors]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |L01XH01 |
+ | |[[vorinostat]] | ||
|- | |- | ||
| | | | ||
שורה 24,451: | שורה 24,457: | ||
| | | | ||
| | | | ||
− | | | + | |L01XH02 |
− | |[[ | + | |[[romidepsin]] |
|- | |- | ||
| | | | ||
שורה 24,458: | שורה 24,464: | ||
| | | | ||
| | | | ||
− | | | + | |L01XH03 |
− | |[[ | + | |[[panobinostat]] |
|- | |- | ||
| | | | ||
שורה 24,465: | שורה 24,471: | ||
| | | | ||
| | | | ||
− | | | + | |L01XH04 |
− | |[[ | + | |[[belinostat]] |
|- | |- | ||
| | | | ||
שורה 24,472: | שורה 24,478: | ||
| | | | ||
| | | | ||
− | | | + | |L01XH05 |
− | |[[ | + | |[[entinostat]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |L01XJ |
| | | | ||
− | |[[ | + | |[[Hedgehog pathway inhibitors]] |
|- | |- | ||
| | | | ||
שורה 24,486: | שורה 24,492: | ||
| | | | ||
| | | | ||
− | | | + | |L01XJ01 |
− | |[[ | + | |[[vismodegib]] |
|- | |- | ||
| | | | ||
שורה 24,493: | שורה 24,499: | ||
| | | | ||
| | | | ||
− | | | + | |L01XJ02 |
− | |[[ | + | |[[sonidegib]] |
|- | |- | ||
| | | | ||
שורה 24,500: | שורה 24,506: | ||
| | | | ||
| | | | ||
− | | | + | |L01XJ03 |
− | |[[ | + | |[[glasdegib]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |L01XK |
| | | | ||
− | |[[ | + | |[[Poly (ADP-ribose) polymerase (PARP) inhibitors]] |
|- | |- | ||
| | | | ||
שורה 24,514: | שורה 24,520: | ||
| | | | ||
| | | | ||
− | | | + | |L01XK01 |
− | |[[ | + | |[[olaparib]] |
|- | |- | ||
| | | | ||
שורה 24,521: | שורה 24,527: | ||
| | | | ||
| | | | ||
− | | | + | |L01XK02 |
− | |[[ | + | |[[niraparib]] |
|- | |- | ||
| | | | ||
שורה 24,528: | שורה 24,534: | ||
| | | | ||
| | | | ||
− | | | + | |L01XK03 |
− | |[[ | + | |[[rucaparib]] |
|- | |- | ||
| | | | ||
שורה 24,535: | שורה 24,541: | ||
| | | | ||
| | | | ||
− | | | + | |L01XK04 |
− | | [[ | + | |[[talazoparib]] |
|- | |- | ||
| | | | ||
שורה 24,542: | שורה 24,548: | ||
| | | | ||
| | | | ||
− | | | + | |L01XK05 |
− | |[[ | + | |[[veliparib]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |L01XX |
| | | | ||
− | |[[Other | + | |[[Other antineoplastic agents]] |
|- | |- | ||
| | | | ||
שורה 24,556: | שורה 24,562: | ||
| | | | ||
| | | | ||
− | | | + | |L01XX01 |
− | | | + | |[[Amsacrine]] |
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | |[[ | + | |L01XX02 |
+ | |[[Asparaginase]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |L01XX03 |
+ | |[[Altretamine]] | ||
|- | |- | ||
| | | | ||
שורה 24,577: | שורה 24,583: | ||
| | | | ||
| | | | ||
− | | | + | |L01XX05 |
− | |[[ | + | |[[Hydroxycarbamide]] |
|- | |- | ||
| | | | ||
שורה 24,584: | שורה 24,590: | ||
| | | | ||
| | | | ||
− | | | + | |L01XX07 |
− | |[[ | + | |[[Lonidamine]] |
|- | |- | ||
| | | | ||
שורה 24,591: | שורה 24,597: | ||
| | | | ||
| | | | ||
− | | | + | |L01XX08 |
− | | [[ | + | |[[Pentostatin]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |L01XX09 |
+ | |[[Miltefosine]] (מבוטל) | ||
|- | |- | ||
| | | | ||
שורה 24,605: | שורה 24,611: | ||
| | | | ||
| | | | ||
− | | | + | |L01XX10 |
− | |[[ | + | |[[Masoprocol]] |
|- | |- | ||
| | | | ||
שורה 24,612: | שורה 24,618: | ||
| | | | ||
| | | | ||
− | |L02BB02 | + | |L01XX11 |
− | |[[Nilutamide]] | + | |[[Estramustine]] |
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX14 | ||
+ | |[[Tretinoin]] (מבוטל) | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX16 | ||
+ | |[[Mitoguazone]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX17 | ||
+ | |[[Topotecan]] (מבוטל) | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX18 | ||
+ | |[[Tiazofurine]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX19 | ||
+ | |[[Irinotecan]] (מבוטל) | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX22 | ||
+ | |[[Alitretinoin]] (מבוטל) | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX23 | ||
+ | |[[Mitotane]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX24 | ||
+ | |[[Pegaspargase]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX25 | ||
+ | |[[Bexarotene]] (מבוטל) | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX27 | ||
+ | |[[Arsenic trioxide]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX29 | ||
+ | |[[Denileukin diftitox]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX32 | ||
+ | |[[Bortezomib]] (מבוטל) | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX33 | ||
+ | |[[Celecoxib]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX35 | ||
+ | |[[Anagrelide]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX36 | ||
+ | |[[Oblimersen]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX37 | ||
+ | |[[Sitimagene ceradenovec]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX38 | ||
+ | |[[Vorinostat]] (מבוטל) | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX39 | ||
+ | |[[Romidepsin]] (מבוטל) | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX40 | ||
+ | |[[Omacetaxine mepesuccinate]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX41 | ||
+ | |[[Eribulin]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX42 | ||
+ | |[[Panobinostat]] (מבוטל) | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX43 | ||
+ | |[[Vismodegib]] (מבוטל) | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX44 | ||
+ | |[[aflibercept]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX51 | ||
+ | |[[talimogene laherparepvec]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX52 | ||
+ | |[[venetoclax]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX53 | ||
+ | |[[vosaroxin]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX57 | ||
+ | |[[plitidepsin]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX58 | ||
+ | |[[epacadostat]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX59 | ||
+ | |[[enasidenib]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX62 | ||
+ | |[[ivosidenib]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX66 | ||
+ | |[[selinexor]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX67 | ||
+ | |[[tagraxofusp]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX69 | ||
+ | |[[lurbinectedin]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX70 | ||
+ | |[[axicabtagene ciloleucel]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XX71 | ||
+ | |[[tisagenlecleucel]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XY | ||
+ | | | ||
+ | | | ||
+ | [[Combinations of antineoplastic agents]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XY01 | ||
+ | |[[cytarabine and daunorubicin]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L01XY02 | ||
+ | |[[pertuzumab and trastuzumab]] | ||
+ | |- | ||
+ | | | ||
+ | |L02 | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |[[Endocrine therapy]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | L02A | ||
+ | | | ||
+ | | | ||
+ | |[[Hormones and related agents]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02AA | ||
+ | | | ||
+ | |[[Estrogens]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02AA01 | ||
+ | |[[Diethylstilbestrol]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02AA02 | ||
+ | |[[Polyestradiol phosphate]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02AA03 | ||
+ | |[[Ethinylestradiol]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02AA04 | ||
+ | |[[Fosfestrol]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02AB | ||
+ | | | ||
+ | |[[Progestogens]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02AB01 | ||
+ | |[[Megestrol]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02AB02 | ||
+ | |[[Medroxyprogesterone]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02AB03 | ||
+ | |[[Gestonorone]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02AE | ||
+ | | | ||
+ | |[[Gonadotropin-releasing hormone analogues]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02AE01 | ||
+ | |[[Buserelin]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02AE02 | ||
+ | |[[Leuprorelin]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02AE03 | ||
+ | |[[Goserelin]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02AE04 | ||
+ | | [[Triptorelin]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02AE05 | ||
+ | |[[Histrelin]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02AX | ||
+ | | | ||
+ | |[[Other hormones]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |empty | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | L02B | ||
+ | | | ||
+ | | | ||
+ | |[[Hormone antagonists and related agents]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02BA | ||
+ | | | ||
+ | |[[Anti-estrogens]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02BA01 | ||
+ | |[[Tamoxifen]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02BA02 | ||
+ | |[[Toremifene]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02BA03 | ||
+ | | [[Fulvestrant]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02BB | ||
+ | | | ||
+ | |[[Anti-androgens]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02BB01 | ||
+ | |[[Flutamide]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02BB02 | ||
+ | |[[Nilutamide]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02BB03 | ||
+ | |[[Bicalutamide]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02BG | ||
+ | | | ||
+ | |[[Aromatase inhibitors]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02BG01 | ||
+ | |[[Aminogluthetimide]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02BG02 | ||
+ | |[[Formestane]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02BG03 | ||
+ | | [[Anastrozole]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02BG04 | ||
+ | |[[Letrozole]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02BG05 | ||
+ | |[[Vorozole]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02BG06 | ||
+ | | [[Exemestane]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02BX | ||
+ | | | ||
+ | |[[Other hormone antagonists and related agents]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02BX01 | ||
+ | |[[Abarelix]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02BX02 | ||
+ | |[[Degarelix]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L02BX03 | ||
+ | |[[Abiraterone]] | ||
+ | |- | ||
+ | | | ||
+ | |L03 | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |[[Immunostimulants]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | |L03A | ||
+ | | | ||
+ | | | ||
+ | |[[Immunostimulants]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L03AA | ||
+ | | | ||
+ | |[[Colony stimulating factors]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L03AA02 | ||
+ | |[[Filgrastim]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L03AA03 | ||
+ | |[[Molgramostim]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L03AA09 | ||
+ | | [[Sargramostim]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L03AA10 | ||
+ | |[[Lenograstim]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L03AA12 | ||
+ | |[[Ancestim]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L03AA13 | ||
+ | |[[Pegfilgrastim]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L03AA14 | ||
+ | |[[Lipegfilgrastim]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L03AB | ||
+ | | | ||
+ | | [[Interferons]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L03AB01 | ||
+ | |[[Interferon alfa natural]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L03AB02 | ||
+ | |[[Interferon beta natural]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L03AB03 | ||
+ | |[[Interferon gamma]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L03AB04 | ||
+ | |[[Interferon alfa-2a]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |L03AB05 | ||
+ | |[[Interferon alfa-2b]] | ||
|- | |- | ||
| | | | ||
שורה 24,619: | שורה 25,277: | ||
| | | | ||
| | | | ||
− | | | + | |L03AB06 |
− | |[[ | + | |[[Interferon alfa-n1]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |L03AB07 |
+ | |[[Interferon beta-1a]] | ||
|- | |- | ||
| | | | ||
שורה 24,633: | שורה 25,291: | ||
| | | | ||
| | | | ||
− | | | + | |L03AB08 |
− | |[[ | + | |[[Interferon beta-1b]] |
|- | |- | ||
| | | | ||
שורה 24,640: | שורה 25,298: | ||
| | | | ||
| | | | ||
− | | | + | |L03AB09 |
− | |[[ | + | |[[Interferon alfacon-1]] |
|- | |- | ||
| | | | ||
שורה 24,647: | שורה 25,305: | ||
| | | | ||
| | | | ||
− | | | + | |L03AB10 |
− | | [[ | + | |[[Peginterferon alfa-2b]] |
|- | |- | ||
| | | | ||
שורה 24,654: | שורה 25,312: | ||
| | | | ||
| | | | ||
− | | | + | |L03AB11 |
− | |[[ | + | |[[Peginterferon alfa-2a]] |
|- | |- | ||
| | | | ||
שורה 24,661: | שורה 25,319: | ||
| | | | ||
| | | | ||
− | | | + | |L03AB12 |
− | |[[ | + | |[[Albinterferon alfa-2b]] |
|- | |- | ||
| | | | ||
שורה 24,668: | שורה 25,326: | ||
| | | | ||
| | | | ||
− | | | + | |L03AB60 |
− | | [[ | + | |[[Peginterferon alfa-2b, combinations]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |L03AB61 |
+ | |[[Peginterferon alfa-2a, combinations]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |L03AC | ||
| | | | ||
− | + | |[[Interleukins]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 24,689: | שורה 25,347: | ||
| | | | ||
| | | | ||
− | | | + | |L03AC01 |
− | |[[ | + | |[[Aldesleukin]] |
|- | |- | ||
| | | | ||
שורה 24,696: | שורה 25,354: | ||
| | | | ||
| | | | ||
− | | | + | |L03AC02 |
− | |[[ | + | | [[Oprelvekin]] |
|- | |- | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
+ | |L03AX | ||
| | | | ||
− | |[[ | + | |[[Other immunostimulants]] |
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | |[[ | + | |L03AX01 |
+ | |[[Lentinan]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |L03AX02 |
+ | |[[Roquinimex]] | ||
|- | |- | ||
| | | | ||
שורה 24,724: | שורה 25,382: | ||
| | | | ||
| | | | ||
− | | | + | |L03AX03 |
− | |[[ | + | |[[BCG vaccine]] |
|- | |- | ||
| | | | ||
שורה 24,731: | שורה 25,389: | ||
| | | | ||
| | | | ||
− | | | + | |L03AX04 |
− | |[[ | + | | [[Pegademase]] |
|- | |- | ||
| | | | ||
שורה 24,738: | שורה 25,396: | ||
| | | | ||
| | | | ||
− | | | + | |L03AX05 |
− | | [[ | + | |[[Pidotimod]] |
|- | |- | ||
| | | | ||
שורה 24,745: | שורה 25,403: | ||
| | | | ||
| | | | ||
− | | | + | |L03AX07 |
− | |[[ | + | |[[Poly I:C]] |
|- | |- | ||
| | | | ||
שורה 24,752: | שורה 25,410: | ||
| | | | ||
| | | | ||
− | | | + | |L03AX08 |
− | |[[ | + | |[[Poly ICLC]] |
|- | |- | ||
| | | | ||
שורה 24,759: | שורה 25,417: | ||
| | | | ||
| | | | ||
− | | | + | |L03AX09 |
− | |[[ | + | | [[Thymopentin]] |
|- | |- | ||
| | | | ||
שורה 24,766: | שורה 25,424: | ||
| | | | ||
| | | | ||
− | | | + | |L03AX10 |
− | |[[ | + | |[[Immunocyanin]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | | [[ | + | |L03AX11 |
+ | |[[Tasonermin]] | ||
|- | |- | ||
| | | | ||
שורה 24,780: | שורה 25,438: | ||
| | | | ||
| | | | ||
− | | | + | |L03AX12 |
− | |[[ | + | |[[Melanoma vaccine]] |
|- | |- | ||
| | | | ||
שורה 24,787: | שורה 25,445: | ||
| | | | ||
| | | | ||
− | | | + | |L03AX13 |
− | |[[ | + | |[[Glatiramer acetate]] |
|- | |- | ||
| | | | ||
שורה 24,794: | שורה 25,452: | ||
| | | | ||
| | | | ||
− | | | + | |L03AX14 |
− | |[[ | + | | [[Histamine dihydrochloride]] |
|- | |- | ||
| | | | ||
שורה 24,801: | שורה 25,459: | ||
| | | | ||
| | | | ||
− | | | + | |L03AX15 |
− | |[[ | + | | [[Mifamurtide]] |
|- | |- | ||
| | | | ||
שורה 24,808: | שורה 25,466: | ||
| | | | ||
| | | | ||
− | | | + | |L03AX16 |
− | |[[ | + | |[[Plerixafor]] |
|- | |- | ||
| | | | ||
שורה 24,815: | שורה 25,473: | ||
| | | | ||
| | | | ||
− | | | + | |L03AX17 |
− | |[[ | + | |[[Sipuleucel-T]] |
|- | |- | ||
| | | | ||
+ | |L04 | ||
| | | | ||
| | | | ||
| | | | ||
− | + | |[[Immunosuppressants]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
+ | | L04A | ||
| | | | ||
| | | | ||
− | + | |[[Immunosuppressants]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |L04AA | ||
| | | | ||
− | + | |[[Selective immunosuppressants]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 24,843: | שורה 25,501: | ||
| | | | ||
| | | | ||
− | | | + | |L04AA02 |
− | |[[ | + | |[[Muromonab-CD3]] |
|- | |- | ||
| | | | ||
שורה 24,850: | שורה 25,508: | ||
| | | | ||
| | | | ||
− | | | + | |L04AA03 |
− | |[[ | + | |[[Antilymphocyte immunoglobulin (horse)]] |
|- | |- | ||
| | | | ||
שורה 24,857: | שורה 25,515: | ||
| | | | ||
| | | | ||
− | | | + | |L04AA04 |
− | |[[ | + | |[[Antithymocyte immunoglobulin (rabbit)]] |
|- | |- | ||
| | | | ||
שורה 24,864: | שורה 25,522: | ||
| | | | ||
| | | | ||
− | | | + | |L04AA06 |
− | |[[ | + | |[[Mycophenolic acid]] |
|- | |- | ||
| | | | ||
שורה 24,871: | שורה 25,529: | ||
| | | | ||
| | | | ||
− | | | + | |L04AA10 |
− | |[[ | + | |[[Sirolimus]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |L04AA13 |
+ | |[[Leflunomide]] | ||
|- | |- | ||
| | | | ||
שורה 24,885: | שורה 25,543: | ||
| | | | ||
| | | | ||
− | | | + | |L04AA15 |
− | |[[ | + | |[[Alefacept]] |
|- | |- | ||
| | | | ||
שורה 24,892: | שורה 25,550: | ||
| | | | ||
| | | | ||
− | | | + | |L04AA18 |
− | | [[ | + | |[[Everolimus]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |L04AA19 |
+ | |[[Gusperimus]] | ||
|- | |- | ||
| | | | ||
שורה 24,906: | שורה 25,564: | ||
| | | | ||
| | | | ||
− | | | + | |L04AA21 |
− | |[[ | + | | [[Efalizumab]] |
|- | |- | ||
| | | | ||
שורה 24,913: | שורה 25,571: | ||
| | | | ||
| | | | ||
− | | | + | |L04AA22 |
− | |[[ | + | | [[Abetimus]] |
|- | |- | ||
| | | | ||
שורה 24,920: | שורה 25,578: | ||
| | | | ||
| | | | ||
− | | | + | |L04AA23 |
− | |[[ | + | |[[Natalizumab]] |
|- | |- | ||
| | | | ||
שורה 24,927: | שורה 25,585: | ||
| | | | ||
| | | | ||
− | | | + | |L04AA24 |
− | | [[ | + | |[[Abatacept]] |
|- | |- | ||
| | | | ||
שורה 24,934: | שורה 25,592: | ||
| | | | ||
| | | | ||
− | | | + | |L04AA25 |
− | |[[ | + | | [[Eculizumab]] |
|- | |- | ||
| | | | ||
שורה 24,941: | שורה 25,599: | ||
| | | | ||
| | | | ||
− | | | + | |L04AA26 |
− | |[[ | + | | [[Belimumab]] |
|- | |- | ||
| | | | ||
שורה 24,948: | שורה 25,606: | ||
| | | | ||
| | | | ||
− | | | + | |L04AA27 |
− | |[[ | + | | [[Fingolimod]] |
|- | |- | ||
| | | | ||
שורה 24,955: | שורה 25,613: | ||
| | | | ||
| | | | ||
− | | | + | |L04AA28 |
− | | [[ | + | |[[Belatacept]] |
|- | |- | ||
| | | | ||
שורה 24,962: | שורה 25,620: | ||
| | | | ||
| | | | ||
− | | | + | |L04AA29 |
− | |[[ | + | |[[Tofacitinib]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |L04AB | ||
| | | | ||
− | + | |[[Tumor necrosis factor alpha (TNF-α) inhibitors]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 24,976: | שורה 25,634: | ||
| | | | ||
| | | | ||
− | | | + | |L04AB01 |
− | |[[ | + | |[[Etanercept]] |
|- | |- | ||
| | | | ||
שורה 24,983: | שורה 25,641: | ||
| | | | ||
| | | | ||
− | | | + | |L04AB02 |
− | |[[ | + | |[[Infliximab]] |
|- | |- | ||
| | | | ||
שורה 24,990: | שורה 25,648: | ||
| | | | ||
| | | | ||
− | | | + | |L04AB03 |
− | | [[ | + | |[[Afelimomab]] |
|- | |- | ||
| | | | ||
שורה 24,997: | שורה 25,655: | ||
| | | | ||
| | | | ||
− | | | + | |L04AB04 |
− | | [[ | + | |[[Adalimumab]] |
|- | |- | ||
| | | | ||
שורה 25,004: | שורה 25,662: | ||
| | | | ||
| | | | ||
− | | | + | |L04AB05 |
− | |[[ | + | |[[Certolizumab pegol]] |
|- | |- | ||
| | | | ||
שורה 25,011: | שורה 25,669: | ||
| | | | ||
| | | | ||
− | | | + | |L04AB06 |
− | |[[ | + | |[[Golimumab]] |
|- | |- | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
+ | |L04AC | ||
| | | | ||
− | |[[ | + | |[[Interleukin inhibitors]] |
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | |[[ | + | |L04AC01 |
+ | |[[Daclizumab]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |L04AC02 |
+ | |[[Basiliximab]] | ||
|- | |- | ||
| | | | ||
שורה 25,039: | שורה 25,697: | ||
| | | | ||
| | | | ||
− | | | + | |L04AC03 |
− | |[[ | + | |[[Anakinra]] |
|- | |- | ||
| | | | ||
שורה 25,046: | שורה 25,704: | ||
| | | | ||
| | | | ||
− | | | + | |L04AC04 |
− | |[[ | + | |[[Rilonacept]] |
|- | |- | ||
| | | | ||
שורה 25,053: | שורה 25,711: | ||
| | | | ||
| | | | ||
− | | | + | |L04AC05 |
− | |[[ | + | |[[Ustekinumab]] |
|- | |- | ||
| | | | ||
שורה 25,060: | שורה 25,718: | ||
| | | | ||
| | | | ||
− | | | + | |L04AC06 |
− | |[[ | + | |[[Mepolizumab]] |
|- | |- | ||
| | | | ||
שורה 25,067: | שורה 25,725: | ||
| | | | ||
| | | | ||
− | | | + | |L04AC07 |
− | |[[ | + | |[[Tocilizumab]] |
|- | |- | ||
| | | | ||
שורה 25,074: | שורה 25,732: | ||
| | | | ||
| | | | ||
− | | | + | |L04AC08 |
− | |[[ | + | |[[Canakinumab]] |
|- | |- | ||
| | | | ||
שורה 25,081: | שורה 25,739: | ||
| | | | ||
| | | | ||
− | | | + | |L04AC09 |
− | |[[ | + | |[[Briakinumab]] |
|- | |- | ||
| | | | ||
שורה 25,088: | שורה 25,746: | ||
| | | | ||
| | | | ||
− | | | + | |L04AC10 |
− | |[[ | + | |[[Secukinumab]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |L04AD | ||
| | | | ||
− | + | |[[Calcineurin inhibitors]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 25,102: | שורה 25,760: | ||
| | | | ||
| | | | ||
− | | | + | |L04AD01 |
− | | [[ | + | |[[Ciclosporin]] |
|- | |- | ||
| | | | ||
שורה 25,109: | שורה 25,767: | ||
| | | | ||
| | | | ||
− | | | + | |L04AD02 |
− | | [[ | + | |[[Tacrolimus]] |
|- | |- | ||
| | | | ||
שורה 25,116: | שורה 25,774: | ||
| | | | ||
| | | | ||
− | | | + | |L04AD03 |
− | |[[ | + | |[[Voclosporin]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |L04AX | ||
| | | | ||
− | + | |[[Other immunosuppressants]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 25,130: | שורה 25,788: | ||
| | | | ||
| | | | ||
− | | | + | |L04AX01 |
− | | [[ | + | |[[Azathioprine]] |
|- | |- | ||
| | | | ||
שורה 25,137: | שורה 25,795: | ||
| | | | ||
| | | | ||
− | | | + | |L04AX02 |
− | | [[ | + | |[[Thalidomide]] |
|- | |- | ||
| | | | ||
שורה 25,144: | שורה 25,802: | ||
| | | | ||
| | | | ||
− | | | + | |L04AX03 |
− | | [[ | + | |[[Methotrexate]] |
|- | |- | ||
| | | | ||
שורה 25,151: | שורה 25,809: | ||
| | | | ||
| | | | ||
− | | | + | |L04AX04 |
− | |[[ | + | |[[Lenalidomide]] |
|- | |- | ||
| | | | ||
שורה 25,158: | שורה 25,816: | ||
| | | | ||
| | | | ||
− | | | + | |L04AX05 |
− | |[[ | + | |[[Pirfenidone]] |
|- | |- | ||
+ | |{{עוגן2|עוגןM}}{{כ}}M | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |[[Musculo-skeletal system]] |
|- | |- | ||
| | | | ||
+ | |M01 | ||
| | | | ||
| | | | ||
| | | | ||
− | + | |[[Anti-inflammatory and antirheumatic products]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
+ | |M01A | ||
| | | | ||
| | | | ||
− | + | |[[Anti-inflammatory and antirheumatic products, non-steroids]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M01AA | ||
| | | | ||
− | + | |[[Butylpyrazolidines]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 25,193: | שורה 25,851: | ||
| | | | ||
| | | | ||
− | | | + | |M01AA01 |
− | |[[ | + | |[[Phenylbutazone]] |
|- | |- | ||
| | | | ||
שורה 25,200: | שורה 25,858: | ||
| | | | ||
| | | | ||
− | | | + | |M01AA02 |
− | |[[ | + | |[[Mofebutazone]] |
|- | |- | ||
| | | | ||
שורה 25,207: | שורה 25,865: | ||
| | | | ||
| | | | ||
− | | | + | |M01AA03 |
− | |[[ | + | |[[Oxyphenbutazone]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M01AA05 |
+ | |[[Clofezone]] | ||
|- | |- | ||
| | | | ||
שורה 25,221: | שורה 25,879: | ||
| | | | ||
| | | | ||
− | | | + | |M01AA06 |
− | |[[ | + | |[[Kebuzone]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M01AB | ||
| | | | ||
− | + | |[[Acetic acid derivatives and related substances]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 25,235: | שורה 25,893: | ||
| | | | ||
| | | | ||
− | | | + | | M01AB01 |
− | |[[ | + | | [[Indometacin]] |
|- | |- | ||
| | | | ||
שורה 25,242: | שורה 25,900: | ||
| | | | ||
| | | | ||
− | | | + | | M01AB02 |
− | |[[ | + | | [[Sulindac]] |
|- | |- | ||
| | | | ||
שורה 25,249: | שורה 25,907: | ||
| | | | ||
| | | | ||
− | | | + | | M01AB03 |
− | |[[ | + | | [[Tolmetin]] |
|- | |- | ||
| | | | ||
שורה 25,256: | שורה 25,914: | ||
| | | | ||
| | | | ||
− | | | + | | M01AB04 |
− | |[[ | + | | [[Zomepirac]] |
|- | |- | ||
| | | | ||
שורה 25,263: | שורה 25,921: | ||
| | | | ||
| | | | ||
− | | | + | | M01AB05 |
− | |[[ | + | | [[Diclofenac]] |
|- | |- | ||
| | | | ||
שורה 25,270: | שורה 25,928: | ||
| | | | ||
| | | | ||
− | | | + | | M01AB06 |
− | |[[ | + | | [[Alclofenac]] |
|- | |- | ||
| | | | ||
שורה 25,277: | שורה 25,935: | ||
| | | | ||
| | | | ||
− | | | + | | M01AB07 |
− | |[[ | + | | [[Bumadizone]] |
|- | |- | ||
| | | | ||
שורה 25,284: | שורה 25,942: | ||
| | | | ||
| | | | ||
− | | | + | | M01AB08 |
− | |[[ | + | | [[Etodolac]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | | M01AB09 |
+ | | [[Lonazolac]] | ||
|- | |- | ||
| | | | ||
שורה 25,298: | שורה 25,956: | ||
| | | | ||
| | | | ||
− | | | + | | M01AB10 |
− | |[[ | + | | [[Fentiazac]] |
|- | |- | ||
| | | | ||
שורה 25,305: | שורה 25,963: | ||
| | | | ||
| | | | ||
− | | | + | | M01AB11 |
− | |[[ | + | | [[Acemetacin]] |
|- | |- | ||
| | | | ||
שורה 25,312: | שורה 25,970: | ||
| | | | ||
| | | | ||
− | | | + | | M01AB12 |
− | |[[ | + | | [[Difenpiramide]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | | M01AB13 |
+ | | [[Oxametacin]] | ||
|- | |- | ||
| | | | ||
שורה 25,326: | שורה 25,984: | ||
| | | | ||
| | | | ||
− | | | + | | M01AB14 |
− | |[[ | + | | [[Proglumetacin]] |
|- | |- | ||
| | | | ||
שורה 25,333: | שורה 25,991: | ||
| | | | ||
| | | | ||
− | | | + | | M01AB15 |
− | |[[ | + | | [[Ketorolac]] |
|- | |- | ||
| | | | ||
שורה 25,340: | שורה 25,998: | ||
| | | | ||
| | | | ||
− | | | + | | M01AB16 |
− | |[[ | + | | [[Aceclofenac]] |
|- | |- | ||
| | | | ||
שורה 25,347: | שורה 26,005: | ||
| | | | ||
| | | | ||
− | | | + | | M01AB17 |
− | |[[ | + | | [[Bufexamac]] |
|- | |- | ||
| | | | ||
שורה 25,354: | שורה 26,012: | ||
| | | | ||
| | | | ||
− | | | + | | M01AB51 |
− | |[[ | + | | [[Indometacin, combinations]] |
|- | |- | ||
− | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
− | |[[ | + | | M01AB55 |
+ | | [[Diclofenac, combinations]] | ||
|- | |- | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
+ | |M01AC | ||
| | | | ||
− | |[[ | + | |[[Oxicams]] |
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | |[[ | + | |M01AC01 |
+ | |[[Piroxicam]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M01AC02 |
+ | |[[Tenoxicam]] | ||
|- | |- | ||
| | | | ||
שורה 25,389: | שורה 26,047: | ||
| | | | ||
| | | | ||
− | | | + | |M01AC04 |
− | |[[ | + | |[[Droxicam]] |
|- | |- | ||
| | | | ||
שורה 25,396: | שורה 26,054: | ||
| | | | ||
| | | | ||
− | | | + | |M01AC05 |
− | |[[ | + | | [[Lornoxicam]] |
|- | |- | ||
| | | | ||
שורה 25,403: | שורה 26,061: | ||
| | | | ||
| | | | ||
− | | | + | |M01AC06 |
− | |[[ | + | |[[Meloxicam]] |
|- | |- | ||
| | | | ||
שורה 25,410: | שורה 26,068: | ||
| | | | ||
| | | | ||
− | | | + | |M01AC56 |
− | |[[ | + | | [[Meloxicam, combinations]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M01AE | ||
| | | | ||
− | + | |[[Propionic acid derivatives]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M01AE01 |
+ | |[[Ibuprofen]] | ||
|- | |- | ||
| | | | ||
שורה 25,431: | שורה 26,089: | ||
| | | | ||
| | | | ||
− | | | + | |M01AE02 |
− | | [[ | + | |[[Naproxen]] |
|- | |- | ||
| | | | ||
שורה 25,438: | שורה 26,096: | ||
| | | | ||
| | | | ||
− | | | + | |M01AE03 |
− | | [[ | + | |[[Ketoprofen]] |
|- | |- | ||
| | | | ||
שורה 25,445: | שורה 26,103: | ||
| | | | ||
| | | | ||
− | | | + | |M01AE04 |
− | | [[ | + | |[[Fenoprofen]] |
|- | |- | ||
| | | | ||
שורה 25,452: | שורה 26,110: | ||
| | | | ||
| | | | ||
− | | | + | |M01AE05 |
− | | [[ | + | |[[Fenbufen]] |
|- | |- | ||
| | | | ||
שורה 25,459: | שורה 26,117: | ||
| | | | ||
| | | | ||
− | | | + | |M01AE06 |
− | | [[ | + | |[[Benoxaprofen]] |
|- | |- | ||
| | | | ||
שורה 25,466: | שורה 26,124: | ||
| | | | ||
| | | | ||
− | | | + | |M01AE07 |
− | | [[ | + | |[[Suprofen]] |
|- | |- | ||
| | | | ||
שורה 25,473: | שורה 26,131: | ||
| | | | ||
| | | | ||
− | | | + | |M01AE08 |
− | | [[ | + | |[[Pirprofen]] |
|- | |- | ||
| | | | ||
שורה 25,480: | שורה 26,138: | ||
| | | | ||
| | | | ||
− | | | + | |M01AE09 |
− | | [[ | + | |[[Flurbiprofen]] |
|- | |- | ||
| | | | ||
שורה 25,487: | שורה 26,145: | ||
| | | | ||
| | | | ||
− | | | + | |M01AE10 |
− | | [[ | + | |[[Indoprofen]] |
|- | |- | ||
| | | | ||
שורה 25,494: | שורה 26,152: | ||
| | | | ||
| | | | ||
− | | | + | |M01AE11 |
− | | [[ | + | |[[Tiaprofenic acid]] |
|- | |- | ||
| | | | ||
שורה 25,501: | שורה 26,159: | ||
| | | | ||
| | | | ||
− | | | + | |M01AE12 |
− | | [[ | + | |[[Oxaprozin]] |
|- | |- | ||
| | | | ||
שורה 25,508: | שורה 26,166: | ||
| | | | ||
| | | | ||
− | | | + | |M01AE13 |
− | | [[ | + | |[[Ibuproxam]] |
|- | |- | ||
| | | | ||
שורה 25,515: | שורה 26,173: | ||
| | | | ||
| | | | ||
− | | | + | |M01AE14 |
− | | [[ | + | |[[Dexibuprofen]] |
|- | |- | ||
| | | | ||
שורה 25,522: | שורה 26,180: | ||
| | | | ||
| | | | ||
− | | | + | |M01AE15 |
− | | [[ | + | |[[Flunoxaprofen]] |
|- | |- | ||
| | | | ||
שורה 25,529: | שורה 26,187: | ||
| | | | ||
| | | | ||
− | | | + | |M01AE16 |
− | | [[ | + | |[[Alminoprofen]] |
|- | |- | ||
| | | | ||
שורה 25,536: | שורה 26,194: | ||
| | | | ||
| | | | ||
− | | | + | |M01AE17 |
− | | [[ | + | |[[Dexketoprofen]] |
|- | |- | ||
| | | | ||
שורה 25,543: | שורה 26,201: | ||
| | | | ||
| | | | ||
− | | | + | |M01AE18 |
− | | [[ | + | |[[Naproxcinod]] |
|- | |- | ||
| | | | ||
שורה 25,550: | שורה 26,208: | ||
| | | | ||
| | | | ||
− | | | + | |M01AE51 |
− | | [[ | + | |[[Ibuprofen, combinations]] |
|- | |- | ||
| | | | ||
שורה 25,557: | שורה 26,215: | ||
| | | | ||
| | | | ||
− | | | + | |M01AE52 |
− | | [[ | + | |[[Naproxen and esomeprazole]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M01AE53 |
+ | |[[Ketoprofen, combinations]] | ||
|- | |- | ||
| | | | ||
שורה 25,571: | שורה 26,229: | ||
| | | | ||
| | | | ||
− | | | + | |M01AE56 |
− | |[[ | + | |[[Naproxen and misoprostol]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M01AG | ||
| | | | ||
− | + | |[[Fenamates]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 25,585: | שורה 26,243: | ||
| | | | ||
| | | | ||
− | | | + | |M01AG01 |
− | |[[ | + | |[[Mefenamic acid]] |
|- | |- | ||
| | | | ||
שורה 25,592: | שורה 26,250: | ||
| | | | ||
| | | | ||
− | | | + | |M01AG02 |
− | | [[ | + | |[[Tolfenamic acid]] |
|- | |- | ||
| | | | ||
שורה 25,599: | שורה 26,257: | ||
| | | | ||
| | | | ||
− | | | + | |M01AG03 |
− | |[[ | + | |[[Flufenamic acid]] |
|- | |- | ||
| | | | ||
שורה 25,606: | שורה 26,264: | ||
| | | | ||
| | | | ||
− | | | + | |M01AG04 |
− | | [[ | + | |[[Meclofenamic acid]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |M01AH |
| | | | ||
− | |[[ | + | |[[Coxibs]] |
|- | |- | ||
| | | | ||
שורה 25,620: | שורה 26,278: | ||
| | | | ||
| | | | ||
− | | | + | |M01AH01 |
− | |[[ | + | |[[Celecoxib]] |
|- | |- | ||
| | | | ||
שורה 25,627: | שורה 26,285: | ||
| | | | ||
| | | | ||
− | | | + | |M01AH02 |
− | |[[ | + | |[[Rofecoxib]] |
|- | |- | ||
| | | | ||
שורה 25,634: | שורה 26,292: | ||
| | | | ||
| | | | ||
− | | | + | |M01AH03 |
− | |[[ | + | |[[Valdecoxib]] |
|- | |- | ||
| | | | ||
שורה 25,641: | שורה 26,299: | ||
| | | | ||
| | | | ||
− | | | + | |M01AH04 |
− | |[[ | + | |[[Parecoxib]] |
|- | |- | ||
| | | | ||
שורה 25,648: | שורה 26,306: | ||
| | | | ||
| | | | ||
− | | | + | |M01AH05 |
− | |[[ | + | |[[Etoricoxib]] |
|- | |- | ||
| | | | ||
שורה 25,655: | שורה 26,313: | ||
| | | | ||
| | | | ||
− | | | + | |M01AH06 |
− | |[[ | + | |[[Lumiracoxib]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M01AX | ||
| | | | ||
− | + | |[[Other anti-inflammatory and antirheumatic agents, non-steroids]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 25,669: | שורה 26,327: | ||
| | | | ||
| | | | ||
− | | | + | |M01AX01 |
− | |[[ | + | |[[Nabumetone]] |
|- | |- | ||
| | | | ||
שורה 25,676: | שורה 26,334: | ||
| | | | ||
| | | | ||
− | | | + | |M01AX02 |
− | |[[ | + | |[[Niflumic acid]] |
|- | |- | ||
| | | | ||
שורה 25,683: | שורה 26,341: | ||
| | | | ||
| | | | ||
− | | | + | |M01AX04 |
− | |[[ | + | |[[Azapropazone]] |
|- | |- | ||
| | | | ||
שורה 25,690: | שורה 26,348: | ||
| | | | ||
| | | | ||
− | | | + | |M01AX05 |
− | |[[ | + | |[[Glucosamine]] |
|- | |- | ||
| | | | ||
שורה 25,697: | שורה 26,355: | ||
| | | | ||
| | | | ||
− | | | + | |M01AX07 |
− | |[[ | + | |[[Benzydamine]] |
|- | |- | ||
| | | | ||
שורה 25,704: | שורה 26,362: | ||
| | | | ||
| | | | ||
− | | | + | |M01AX12 |
− | |[[ | + | |[[Glucosaminoglycan polysulfate]] |
|- | |- | ||
| | | | ||
שורה 25,711: | שורה 26,369: | ||
| | | | ||
| | | | ||
− | | | + | |M01AX13 |
− | |[[ | + | |[[Proquazone]] |
|- | |- | ||
| | | | ||
שורה 25,718: | שורה 26,376: | ||
| | | | ||
| | | | ||
− | | | + | |M01AX14 |
− | |[[ | + | |[[Orgotein]] |
|- | |- | ||
| | | | ||
שורה 25,725: | שורה 26,383: | ||
| | | | ||
| | | | ||
− | | | + | |M01AX17 |
− | |[[ | + | |[[Nimesulide]] |
|- | |- | ||
| | | | ||
שורה 25,732: | שורה 26,390: | ||
| | | | ||
| | | | ||
− | | | + | |M01AX18 |
− | |[[ | + | |[[Feprazone]] |
|- | |- | ||
| | | | ||
שורה 25,739: | שורה 26,397: | ||
| | | | ||
| | | | ||
− | | | + | |M01AX21 |
− | |[[ | + | |[[Diacerein]] |
|- | |- | ||
| | | | ||
שורה 25,746: | שורה 26,404: | ||
| | | | ||
| | | | ||
− | | | + | |M01AX22 |
− | |[[ | + | |[[Morniflumate]] |
|- | |- | ||
| | | | ||
שורה 25,753: | שורה 26,411: | ||
| | | | ||
| | | | ||
− | | | + | |M01AX23 |
− | |[[ | + | |[[Tenidap]] |
|- | |- | ||
| | | | ||
שורה 25,760: | שורה 26,418: | ||
| | | | ||
| | | | ||
− | | | + | |M01AX24 |
− | |[[ | + | |[[Oxaceprol]] |
|- | |- | ||
| | | | ||
שורה 25,767: | שורה 26,425: | ||
| | | | ||
| | | | ||
− | | | + | |M01AX25 |
− | |[[ | + | |[[Chondroitin sulfate]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M01AX26 |
+ | |[[Avocado and soyabean oil, unsaponifiables]] | ||
|- | |- | ||
| | | | ||
שורה 25,781: | שורה 26,439: | ||
| | | | ||
| | | | ||
− | | | + | |M01AX68 |
− | |[[ | + | |[[Feprazone, combinations]] |
|- | |- | ||
| | | | ||
| | | | ||
+ | |M01B | ||
| | | | ||
| | | | ||
− | + | |[[Anti-inflammatory/antirheumatic agents in combination]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M01BA | ||
| | | | ||
− | + | |[[Anti-inflammatory/antirheumatic agents in combination with corticosteroids]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 25,802: | שורה 26,460: | ||
| | | | ||
| | | | ||
− | | | + | |M01BA01 |
− | |[[ | + | |[[Phenylbutazone and corticosteroids]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M01BA02 |
+ | |[[Dipyrocetyl and corticosteroids]] | ||
|- | |- | ||
| | | | ||
שורה 25,816: | שורה 26,474: | ||
| | | | ||
| | | | ||
− | | | + | |M01BA03 |
− | |[[ | + | |[[Acetylsalicylic acid and corticosteroids]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M01BX | ||
| | | | ||
− | + | |[[Other anti-inflammatory/antirheumatic agents in combination with other drugs]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 25,830: | שורה 26,488: | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |empty |
|- | |- | ||
| | | | ||
| | | | ||
+ | |M01C | ||
| | | | ||
| | | | ||
− | + | |[[Specific antirheumatic agents]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M01CA | ||
| | | | ||
− | + | |[[Quinolines]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 25,851: | שורה 26,509: | ||
| | | | ||
| | | | ||
− | | | + | |M01CA03 |
− | |[[ | + | |[[Oxycinchophen]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |M01CB |
| | | | ||
− | |[[ | + | |[[Gold preparations]] |
|- | |- | ||
| | | | ||
שורה 25,865: | שורה 26,523: | ||
| | | | ||
| | | | ||
− | | | + | |M01CB01 |
− | |[[ | + | |[[Sodium aurothiomalate]] |
|- | |- | ||
| | | | ||
שורה 25,872: | שורה 26,530: | ||
| | | | ||
| | | | ||
− | | | + | |M01CB02 |
− | |[[ | + | |[[Sodium aurothiosulfate]] |
|- | |- | ||
| | | | ||
שורה 25,879: | שורה 26,537: | ||
| | | | ||
| | | | ||
− | | | + | |M01CB03 |
− | |[[ | + | |[[Auranofin]] |
|- | |- | ||
| | | | ||
שורה 25,886: | שורה 26,544: | ||
| | | | ||
| | | | ||
− | | | + | |M01CB04 |
− | |[[ | + | |[[Aurothioglucose]] |
|- | |- | ||
| | | | ||
שורה 25,893: | שורה 26,551: | ||
| | | | ||
| | | | ||
− | | | + | |M01CB05 |
− | |[[ | + | |[[Aurotioprol]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M01CC | ||
| | | | ||
− | + | |[[Penicillamine and similar agents]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 25,907: | שורה 26,565: | ||
| | | | ||
| | | | ||
− | | | + | |M01CC01 |
− | |[[ | + | |[[Penicillamine]] |
|- | |- | ||
| | | | ||
שורה 25,914: | שורה 26,572: | ||
| | | | ||
| | | | ||
− | | | + | |M01CC02 |
− | |[[ | + | |[[Bucillamine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M01CX | ||
| | | | ||
− | + | |[[Other specific antirheumatic agents]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 25,928: | שורה 26,586: | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |empty |
|- | |- | ||
| | | | ||
+ | |M02 | ||
| | | | ||
| | | | ||
| | | | ||
− | + | |[[Topical products for joint and muscular pain]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
+ | |M02A | ||
| | | | ||
| | | | ||
− | + | |[[Topical products for joint and muscular pain]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M02AA | ||
| | | | ||
− | + | |[[Anti-inflammatory preparations, non-steroids for topical use]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 25,956: | שורה 26,614: | ||
| | | | ||
| | | | ||
− | | | + | |M02AA01 |
− | |[[ | + | |[[Phenylbutazone]] |
|- | |- | ||
| | | | ||
שורה 25,963: | שורה 26,621: | ||
| | | | ||
| | | | ||
− | | | + | |M02AA02 |
− | |[[ | + | |[[Mofebutazone]] |
|- | |- | ||
| | | | ||
שורה 25,970: | שורה 26,628: | ||
| | | | ||
| | | | ||
− | | | + | |M02AA03 |
− | |[[ | + | |[[Clofezone]] |
|- | |- | ||
| | | | ||
שורה 25,977: | שורה 26,635: | ||
| | | | ||
| | | | ||
− | | | + | |M02AA04 |
− | |[[ | + | |[[Oxyphenbutazone]] |
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | |[[ | + | |M02AA05 |
+ | |[[Benzydamine]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M02AA06 |
+ | |[[Etofenamate]] | ||
|- | |- | ||
| | | | ||
שורה 25,998: | שורה 26,656: | ||
| | | | ||
| | | | ||
− | | | + | |M02AA07 |
− | |[[ | + | |[[Piroxicam]] |
|- | |- | ||
| | | | ||
שורה 26,005: | שורה 26,663: | ||
| | | | ||
| | | | ||
− | | | + | |M02AA08 |
− | |[[ | + | |[[Felbinac]] |
|- | |- | ||
| | | | ||
שורה 26,012: | שורה 26,670: | ||
| | | | ||
| | | | ||
− | | | + | |M02AA09 |
− | |[[ | + | |[[Bufexamac]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M02AA10 |
+ | |[[Ketoprofen]] | ||
|- | |- | ||
| | | | ||
שורה 26,026: | שורה 26,684: | ||
| | | | ||
| | | | ||
− | | | + | |M02AA11 |
− | | | + | |[[Bendazac]] |
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | |[[ | + | |M02AA12 |
+ | |[[Naproxen]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M02AA13 |
+ | |[[Ibuprofen]] | ||
|- | |- | ||
| | | | ||
שורה 26,047: | שורה 26,705: | ||
| | | | ||
| | | | ||
− | | | + | |M02AA14 |
− | |[[ | + | |[[Fentiazac]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M02AA15 |
+ | |[[Diclofenac]] | ||
|- | |- | ||
| | | | ||
שורה 26,061: | שורה 26,719: | ||
| | | | ||
| | | | ||
− | | | + | |M02AA16 |
− | |[[ | + | |[[Feprazone]] |
|- | |- | ||
| | | | ||
שורה 26,068: | שורה 26,726: | ||
| | | | ||
| | | | ||
− | | | + | |M02AA17 |
− | |[[ | + | |[[Niflumic acid]] |
|- | |- | ||
| | | | ||
שורה 26,075: | שורה 26,733: | ||
| | | | ||
| | | | ||
− | | | + | |M02AA18 |
− | |[[ | + | |[[Meclofenamic acid]] |
|- | |- | ||
| | | | ||
שורה 26,082: | שורה 26,740: | ||
| | | | ||
| | | | ||
− | | | + | |M02AA19 |
− | |[[ | + | |[[Flurbiprofen]] |
|- | |- | ||
| | | | ||
שורה 26,089: | שורה 26,747: | ||
| | | | ||
| | | | ||
− | | | + | |M02AA21 |
− | |[[ | + | |[[Tolmetin]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M02AA22 |
+ | |[[Suxibuzone]] | ||
|- | |- | ||
| | | | ||
שורה 26,103: | שורה 26,761: | ||
| | | | ||
| | | | ||
− | | | + | |M02AA23 |
− | |[[ | + | |[[Indometacin]] |
|- | |- | ||
| | | | ||
שורה 26,110: | שורה 26,768: | ||
| | | | ||
| | | | ||
− | | | + | |M02AA24 |
− | |[[ | + | |[[Nifenazone]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M02AA25 |
+ | |[[Aceclofenac]] | ||
|- | |- | ||
| | | | ||
שורה 26,124: | שורה 26,782: | ||
| | | | ||
| | | | ||
− | | | + | |M02AA26 |
− | | | + | |[[Nimesulide]] |
|- | |- | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
+ | |M02AB | ||
| | | | ||
− | |[[ | + | |[[Capsaicin and similar agents]] |
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | |[[ | + | |M02AB01 |
+ | |[[Capsaicin]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M02AB02 |
+ | |[[Zucapsaicin]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M02AC | ||
| | | | ||
− | + | |[[Preparations with salicylic acid derivatives]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 26,159: | שורה 26,817: | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |empty |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M02AX | ||
| | | | ||
− | + | |[[Other topical products for joint and muscular pain]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 26,173: | שורה 26,831: | ||
| | | | ||
| | | | ||
− | | | + | |M02AX02 |
− | |[[ | + | |[[Tolazoline]] |
|- | |- | ||
| | | | ||
שורה 26,180: | שורה 26,838: | ||
| | | | ||
| | | | ||
− | | | + | |M02AX03 |
− | |[[ | + | |[[Dimethyl sulfoxide]] |
|- | |- | ||
| | | | ||
שורה 26,187: | שורה 26,845: | ||
| | | | ||
| | | | ||
− | | | + | |M02AX05 |
− | |[[ | + | |[[Idrocilamide]] |
|- | |- | ||
| | | | ||
שורה 26,194: | שורה 26,852: | ||
| | | | ||
| | | | ||
− | | | + | |M02AX10 |
− | |[[ | + | |[[Various]] |
|- | |- | ||
| | | | ||
+ | |M03 | ||
| | | | ||
| | | | ||
| | | | ||
− | + | |[[Muscle relaxants]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
+ | |M03A | ||
| | | | ||
| | | | ||
− | + | |[[Muscle relaxants, peripherally acting agents]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M03AA | ||
| | | | ||
− | + | |[[Curare alkaloids]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 26,222: | שורה 26,880: | ||
| | | | ||
| | | | ||
− | | | + | |M03AA01 |
− | |[[ | + | |[[Alcuronium]] |
|- | |- | ||
| | | | ||
שורה 26,229: | שורה 26,887: | ||
| | | | ||
| | | | ||
− | | | + | |M03AA02 |
− | |[[ | + | |[[Tubocurarine]] |
|- | |- | ||
| | | | ||
שורה 26,236: | שורה 26,894: | ||
| | | | ||
| | | | ||
− | | | + | |M03AA04 |
− | |[[ | + | |[[Dimethyltubocurarine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M03AB | ||
| | | | ||
− | + | |[[Choline derivatives]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 26,250: | שורה 26,908: | ||
| | | | ||
| | | | ||
− | | | + | |M03AB01 |
− | |[[ | + | |[[Suxamethonium]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | | M03AC | ||
| | | | ||
− | + | |[[Other quaternary ammonium compounds]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 26,264: | שורה 26,922: | ||
| | | | ||
| | | | ||
− | | | + | |M03AC01 |
− | |[[ | + | |[[Pancuronium]] |
|- | |- | ||
| | | | ||
שורה 26,271: | שורה 26,929: | ||
| | | | ||
| | | | ||
− | | | + | |M03AC02 |
− | |[[ | + | |[[Gallamine]] |
|- | |- | ||
| | | | ||
שורה 26,278: | שורה 26,936: | ||
| | | | ||
| | | | ||
− | | | + | |M03AC03 |
− | |[[ | + | |[[Vecuronium]] |
|- | |- | ||
| | | | ||
שורה 26,285: | שורה 26,943: | ||
| | | | ||
| | | | ||
− | | | + | |M03AC04 |
− | |[[ | + | |[[Atracurium]] |
|- | |- | ||
| | | | ||
שורה 26,292: | שורה 26,950: | ||
| | | | ||
| | | | ||
− | | | + | |M03AC05 |
− | |[[ | + | |[[Hexafluronium]] |
|- | |- | ||
| | | | ||
שורה 26,299: | שורה 26,957: | ||
| | | | ||
| | | | ||
− | | | + | |M03AC06 |
− | |[[ | + | |[[Pipecuronium bromide]] |
|- | |- | ||
| | | | ||
שורה 26,306: | שורה 26,964: | ||
| | | | ||
| | | | ||
− | | | + | |M03AC07 |
− | |[[ | + | |[[Doxacurium chloride]] |
|- | |- | ||
| | | | ||
שורה 26,313: | שורה 26,971: | ||
| | | | ||
| | | | ||
− | | | + | |M03AC08 |
− | |[[ | + | |[[Fazadinium bromide]] |
|- | |- | ||
| | | | ||
שורה 26,320: | שורה 26,978: | ||
| | | | ||
| | | | ||
− | | | + | |M03AC09 |
− | |[[ | + | |[[Rocuronium bromide]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M03AC10 |
+ | |[[Mivacurium chloride]] | ||
|- | |- | ||
| | | | ||
שורה 26,334: | שורה 26,992: | ||
| | | | ||
| | | | ||
− | | | + | |M03AC11 |
− | |[[ | + | |[[Cisatracurium]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M03AX | ||
| | | | ||
− | + | |[[Other muscle relaxants, peripherally acting agents]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M03AX01 |
+ | |[[Botulinum toxin]] | ||
|- | |- | ||
| | | | ||
| | | | ||
+ | |M03B | ||
| | | | ||
| | | | ||
− | | | + | |[[Muscle relaxants, centrally acting agents]] |
− | |||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |M03BA |
| | | | ||
− | |[[ | + | |[[Carbamic acid esters]] |
|- | |- | ||
| | | | ||
שורה 26,369: | שורה 27,027: | ||
| | | | ||
| | | | ||
− | | | + | |M03BA01 |
− | |[[ | + | |[[Phenprobamate]] |
|- | |- | ||
| | | | ||
שורה 26,376: | שורה 27,034: | ||
| | | | ||
| | | | ||
− | | | + | |M03BA02 |
− | |[[ | + | |[[Carisoprodol]] |
|- | |- | ||
| | | | ||
שורה 26,383: | שורה 27,041: | ||
| | | | ||
| | | | ||
− | | | + | |M03BA03 |
− | |[[ | + | | [[Methocarbamol]] |
|- | |- | ||
| | | | ||
שורה 26,390: | שורה 27,048: | ||
| | | | ||
| | | | ||
− | | | + | |M03BA04 |
− | |[[ | + | | [[Styramate]] |
|- | |- | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
| | | | ||
− | |[[ | + | |M03BA05 |
+ | | [[Febarbamate]] | ||
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | |[[ | + | |M03BA51 |
+ | |[[Phenprobamate, combinations excluding psycholeptics]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M03BA52 |
+ | |[[Carisoprodol, combinations excluding psycholeptics]] | ||
|- | |- | ||
| | | | ||
שורה 26,418: | שורה 27,076: | ||
| | | | ||
| | | | ||
− | | | + | |M03BA53 |
− | |[[ | + | |[[Methocarbamol, combinations excluding psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 26,425: | שורה 27,083: | ||
| | | | ||
| | | | ||
− | | | + | |M03BA71 |
− | |[[ | + | | [[Phenprobamate, combinations with psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 26,432: | שורה 27,090: | ||
| | | | ||
| | | | ||
− | | | + | |M03BA72 |
− | |[[ | + | |[[Carisoprodol, combinations with psycholeptics]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M03BA73 |
+ | |[[Methocarbamol, combinations with psycholeptics]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M03BB | ||
| | | | ||
− | + | |[[Oxazol, thiazine, and triazine derivatives]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M03BB02 |
+ | |[[Chlormezanone]] | ||
|- | |- | ||
| | | | ||
שורה 26,460: | שורה 27,118: | ||
| | | | ||
| | | | ||
− | | | + | |M03BB03 |
− | |[[ | + | |[[Chlorzoxazone]] |
|- | |- | ||
| | | | ||
שורה 26,467: | שורה 27,125: | ||
| | | | ||
| | | | ||
− | | | + | |M03BB52 |
− | |[[ | + | |[[Chlormezanone, combinations excluding psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 26,474: | שורה 27,132: | ||
| | | | ||
| | | | ||
− | | | + | |M03BB53 |
− | |[[ | + | |[[Chlorzoxazone, combinations excluding psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 26,481: | שורה 27,139: | ||
| | | | ||
| | | | ||
− | | | + | |M03BB72 |
− | |[[ | + | |[[Chlormezanone, combinations with psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 26,488: | שורה 27,146: | ||
| | | | ||
| | | | ||
− | | | + | |M03BB73 |
− | |[[ | + | |[[Chlorzoxazone, combinations with psycholeptics]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M03BC | ||
| | | | ||
− | + | |[[Ethers, chemically close to antihistamines]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 26,502: | שורה 27,160: | ||
| | | | ||
| | | | ||
− | | | + | |M03BC01 |
− | |[[ | + | |[[Orphenadrine (citrate)]] |
|- | |- | ||
| | | | ||
שורה 26,509: | שורה 27,167: | ||
| | | | ||
| | | | ||
− | | | + | |M03BC51 |
− | |[[ | + | |[[Orphenadrine, combinations]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M03BX | ||
| | | | ||
− | + | |[[Other centrally acting agents]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 26,523: | שורה 27,181: | ||
| | | | ||
| | | | ||
− | | | + | |M03BX01 |
− | |[[ | + | |[[Baclofen]] |
|- | |- | ||
| | | | ||
שורה 26,530: | שורה 27,188: | ||
| | | | ||
| | | | ||
− | | | + | |M03BX02 |
− | |[[ | + | |[[Tizanidine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M03BX03 |
+ | | [[Pridinol]] | ||
|- | |- | ||
| | | | ||
שורה 26,544: | שורה 27,202: | ||
| | | | ||
| | | | ||
− | | | + | |M03BX04 |
− | |[[ | + | |[[Tolperisone]] |
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | |[[ | + | |M03BX05 |
+ | |[[Thiocolchicoside]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M03BX06 |
+ | | [[Mephenesin]] | ||
|- | |- | ||
| | | | ||
שורה 26,565: | שורה 27,223: | ||
| | | | ||
| | | | ||
− | | | + | |M03BX07 |
− | |[[ | + | | [[Tetrazepam]] |
|- | |- | ||
| | | | ||
שורה 26,572: | שורה 27,230: | ||
| | | | ||
| | | | ||
− | | | + | |M03BX08 |
− | |[[ | + | | [[Cyclobenzaprine]] |
|- | |- | ||
| | | | ||
שורה 26,579: | שורה 27,237: | ||
| | | | ||
| | | | ||
− | | | + | |M03BX09 |
− | | [[ | + | | [[Eperisone]] |
|- | |- | ||
| | | | ||
שורה 26,586: | שורה 27,244: | ||
| | | | ||
| | | | ||
− | | | + | |M03BX30 |
− | | [[ | + | | [[Phenyramidol]] |
|- | |- | ||
| | | | ||
| | | | ||
+ | |M03C | ||
| | | | ||
| | | | ||
− | + | |[[Muscle relaxants, directly acting agents]] | |
− | | [[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M03CA | ||
| | | | ||
− | + | |[[Dantrolene and derivatives]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 26,607: | שורה 27,265: | ||
| | | | ||
| | | | ||
− | | | + | |M03CA01 |
− | |[[ | + | |[[Dantrolene]] |
|- | |- | ||
| | | | ||
+ | |M04 | ||
| | | | ||
| | | | ||
| | | | ||
− | + | |[[Antigout preparations]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
+ | |M04A | ||
| | | | ||
| | | | ||
− | + | |[[Antigout preparations]] | |
− | | [[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M04AA | ||
| | | | ||
− | + | |[[Preparations inhibiting uric acid production]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 26,635: | שורה 27,293: | ||
| | | | ||
| | | | ||
− | | | + | |M04AA01 |
− | |[[ | + | | [[Allopurinol]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M04AA02 |
+ | |[[Tisopurine]] | ||
|- | |- | ||
| | | | ||
שורה 26,649: | שורה 27,307: | ||
| | | | ||
| | | | ||
− | | | + | |M04AA03 |
− | |[[ | + | | [[Febuxostat]] |
|- | |- | ||
| | | | ||
שורה 26,656: | שורה 27,314: | ||
| | | | ||
| | | | ||
− | | | + | |M04AA51 |
− | |[[ | + | |[[Allopurinol, combinations]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M04AB | ||
| | | | ||
− | + | |[[Preparations increasing uric acid excretion]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 26,670: | שורה 27,328: | ||
| | | | ||
| | | | ||
− | | | + | |M04AB01 |
− | |[[ | + | | [[Probenecid]] |
|- | |- | ||
| | | | ||
שורה 26,677: | שורה 27,335: | ||
| | | | ||
| | | | ||
− | | | + | |M04AB02 |
− | |[[ | + | |[[Sulfinpyrazone]] |
|- | |- | ||
| | | | ||
שורה 26,684: | שורה 27,342: | ||
| | | | ||
| | | | ||
− | | | + | |M04AB03 |
− | |[[ | + | | [[Benzbromarone]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M04AB04 |
+ | | [[Isobromindione]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M04AC | ||
| | | | ||
− | + | |[[Preparations with no effect on uric acid metabolism]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 26,705: | שורה 27,363: | ||
| | | | ||
| | | | ||
− | | | + | |M04AC01 |
− | |[[ | + | | [[Colchicine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M04AC02 |
+ | | [[Cinchophen]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M04AX | ||
| | | | ||
− | + | |[[Other antigout preparations]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 26,726: | שורה 27,384: | ||
| | | | ||
| | | | ||
− | | | + | |M04AX01 |
− | |[[ | + | | [[Urate oxidase]] |
|- | |- | ||
| | | | ||
שורה 26,733: | שורה 27,391: | ||
| | | | ||
| | | | ||
− | | | + | |M04AX02 |
− | | [[ | + | |[[Pegloticase]] |
|- | |- | ||
| | | | ||
+ | |M05 | ||
| | | | ||
| | | | ||
| | | | ||
− | + | |[[Drugs for treatment of bone diseases]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
+ | |M05B | ||
| | | | ||
| | | | ||
− | + | |[[Drugs affecting bone structure and mineralization]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M05BA | ||
| | | | ||
− | + | |[[Bisphosphonates]] | |
− | | [[ | ||
|- | |- | ||
| | | | ||
שורה 26,761: | שורה 27,419: | ||
| | | | ||
| | | | ||
− | | | + | |M05BA01 |
− | | [[ | + | |[[Etidronic acid]] |
|- | |- | ||
| | | | ||
שורה 26,768: | שורה 27,426: | ||
| | | | ||
| | | | ||
− | | | + | |M05BA02 |
− | | [[ | + | |[[Clodronic acid]] |
|- | |- | ||
| | | | ||
שורה 26,775: | שורה 27,433: | ||
| | | | ||
| | | | ||
− | | | + | |M05BA03 |
− | | [[ | + | |[[Pamidronic acid]] |
|- | |- | ||
| | | | ||
שורה 26,782: | שורה 27,440: | ||
| | | | ||
| | | | ||
− | | | + | |M05BA04 |
− | | [[ | + | |[[Alendronic acid]] |
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | |[[ | + | |M05BA05 |
+ | |[[Tiludronic acid]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M05BA06 |
+ | |[[Ibandronic acid]] | ||
|- | |- | ||
| | | | ||
שורה 26,803: | שורה 27,461: | ||
| | | | ||
| | | | ||
− | | | + | |M05BA07 |
− | |[[ | + | |[[Risedronic acid]] |
|- | |- | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
| | | | ||
− | |[[ | + | |M05BA08 |
+ | |[[Zoledronic acid]] | ||
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
+ | |M05BB | ||
| | | | ||
− | |[[ | + | |[[Bisphosphonates, combinations]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M05BB01 |
+ | |[[Etidronic acid and calcium, sequential]] | ||
|- | |- | ||
| | | | ||
שורה 26,831: | שורה 27,489: | ||
| | | | ||
| | | | ||
− | | | + | |M05BB02 |
− | | [[ | + | |[[Risedronic acid and calcium, sequential]] |
|- | |- | ||
| | | | ||
שורה 26,838: | שורה 27,496: | ||
| | | | ||
| | | | ||
− | | | + | |M05BB03 |
− | |[[ | + | |[[Alendronic acid and colecalciferol]] |
|- | |- | ||
| | | | ||
שורה 26,845: | שורה 27,503: | ||
| | | | ||
| | | | ||
− | | | + | |M05BB04 |
− | | [[ | + | |[[Risedronic acid, calcium and colecalciferol, sequential]] |
|- | |- | ||
| | | | ||
שורה 26,852: | שורה 27,510: | ||
| | | | ||
| | | | ||
− | | | + | |M05BB05 |
− | |[[ | + | |[[Alendronic acid, calcium and colecalciferol, sequential]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M05BB06 |
+ | |[[Alendronic acid and alfacalcidol, sequential]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M05BC | ||
| | | | ||
− | + | |[[Bone morphogenetic proteins]] | |
− | | [[ | ||
|- | |- | ||
| | | | ||
שורה 26,873: | שורה 27,531: | ||
| | | | ||
| | | | ||
− | | | + | |M05BC01 |
− | |[[ | + | |[[Dibotermin alfa]] |
|- | |- | ||
| | | | ||
שורה 26,880: | שורה 27,538: | ||
| | | | ||
| | | | ||
− | | | + | |M05BC02 |
− | | [[ | + | | [[Eptotermin alfa]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M05BX | ||
| | | | ||
− | + | |[[Other drugs affecting bone structure and mineralization]] | |
− | | [[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M05BX01 |
+ | |[[Ipriflavone]] | ||
|- | |- | ||
| | | | ||
שורה 26,901: | שורה 27,559: | ||
| | | | ||
| | | | ||
− | | | + | |M05BX02 |
− | | [[ | + | |[[luminium chlorohydrate]] |
|- | |- | ||
| | | | ||
שורה 26,908: | שורה 27,566: | ||
| | | | ||
| | | | ||
− | | | + | |M05BX03 |
− | | [[ | + | |[[Strontium ranelate]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |M05BX04 |
+ | |[[Denosumab]] | ||
|- | |- | ||
| | | | ||
+ | |M09 | ||
| | | | ||
| | | | ||
| | | | ||
− | + | |[[Other drugs for disorders of the musculo-skeletal system]] | |
− | | [[ | ||
|- | |- | ||
| | | | ||
| | | | ||
+ | |M09A | ||
| | | | ||
| | | | ||
− | + | |[[Other drugs for disorders of the musculo-skeletal system]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
+ | |M09AA | ||
| | | | ||
− | |[[ | + | |[[Quinine and derivatives]] |
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | |[[ | + | | M09AA01 |
+ | | [[Hydroquinine]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | | M09AA72 |
+ | |[[Quinine, combinations with psycholeptics]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M09AB | ||
| | | | ||
− | + | |[[Enzymes]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 26,964: | שורה 27,622: | ||
| | | | ||
| | | | ||
− | | | + | | M09AB01 |
− | |[[ | + | | [[Chymopapain]] |
|- | |- | ||
| | | | ||
שורה 26,971: | שורה 27,629: | ||
| | | | ||
| | | | ||
− | | | + | | M09AB02 |
− | |[[ | + | |[[Collagenase clostridium histolyticum]] |
|- | |- | ||
| | | | ||
שורה 26,978: | שורה 27,636: | ||
| | | | ||
| | | | ||
− | | | + | | M09AB52 |
− | |[[ | + | |[[Trypsin, combinations]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |M09AX | ||
| | | | ||
− | + | |[[Other drugs for disorders of the musculo-skeletal system]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 26,992: | שורה 27,650: | ||
| | | | ||
| | | | ||
− | | | + | | M09AX01 |
− | |[[ | + | |[[Hyaluronic acid]] |
|- | |- | ||
| | | | ||
שורה 26,999: | שורה 27,657: | ||
| | | | ||
| | | | ||
− | | | + | | M09AX02 |
− | |[[ | + | |[[Chondrocytes, autologous]] |
|- | |- | ||
+ | |{{עוגן2|עוגןN}}{{כ}}N | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
− | + | |[[Nervous system]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
+ | |N01 | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | | [[Anesthetics]] |
|- | |- | ||
| | | | ||
| | | | ||
+ | |N01A | ||
| | | | ||
| | | | ||
− | + | | [[Anesthetics, general]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | | N01AA | ||
| | | | ||
− | + | |[[Ethers]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N01AA01 |
− | |[[ | + | |[[Diethyl ether]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N01AA02 |
− | |[[ | + | |[[Vinyl ether]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | | N01AB | ||
| | | | ||
− | + | |[[Halogenated hydrocarbons]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N01AB01 |
− | |[[ | + | |[[Halothane]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N01AB02 |
− | |[[ | + | |[[Chloroform]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N01AB04 |
− | |[[ | + | |[[Enflurane]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N01AB05 |
− | | [[ | + | |[[Trichloroethylene]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N01AB06 |
− | |[[ | + | |[[Isoflurane]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N01AB07 |
− | |[[ | + | |[[Desflurane]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N01AB08 |
− | |[[ | + | |[[Sevoflurane]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N01AF | ||
| | | | ||
− | + | |[[Barbiturates, plain]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N01AF01 |
− | |[[ | + | |[[Methohexital]] |
|- | |- | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | | | + | | |
− | |[[ | + | |N01AF02 |
+ | |[[Hexobarbital]] | ||
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | | | + | | |
− | |[[ | + | |N01AF03 |
+ | | [[Thiopental]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N01AG |
| | | | ||
− | |[[ | + | |[[Barbiturates in combination with other drugs]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N01AG01 |
− | | [[ | + | |[[Narcobarbital]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N01AH | ||
| | | | ||
− | + | |[[Opioid anesthetics]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N01AH01 |
− | |[[ | + | |[[Fentanyl]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N01AH02 |
− | | [[ | + | |[[Alfentanil]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N01AH03 |
− | |[[ | + | |[[Sufentanil]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N01AH04 |
− | |[[ | + | |[[Phenoperidine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N01AH05 |
− | |[[ | + | | [[Anileridine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N01AH06 |
− | |[[ | + | |[[Remifentanil]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N01AH51 |
− | |[[ | + | |[[Fentanyl, combinations]] |
|- | |- | ||
− | |||
| | | | ||
| | | | ||
| | | | ||
+ | |N01AX | ||
| | | | ||
− | |[[ | + | |[[Other general anesthetics]] |
|- | |- | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | | | + | | |
− | | [[ | + | |N01AX03 |
+ | |[[Ketamine]] | ||
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | | | + | | |
− | | [[ | + | |N01AX04 |
+ | |[[Propanidid]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N01AX05 |
− | |[[ | + | |[[Alfaxalone]] |
|- | |- | ||
| | | | ||
שורה 27,230: | שורה 27,888: | ||
| | | | ||
| | | | ||
− | | | + | |N01AX07 |
− | |[[ | + | | [[Etomidate]] |
|- | |- | ||
| | | | ||
שורה 27,237: | שורה 27,895: | ||
| | | | ||
| | | | ||
− | | | + | |N01AX10 |
− | |[[ | + | |[[Propofol]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N01AX11 |
− | |[[ | + | |[[Sodium oxybate]] |
|- | |- | ||
| | | | ||
שורה 27,251: | שורה 27,909: | ||
| | | | ||
| | | | ||
− | | | + | |N01AX13 |
− | |[[ | + | |[[Nitrous oxide]] |
|- | |- | ||
| | | | ||
שורה 27,258: | שורה 27,916: | ||
| | | | ||
| | | | ||
− | | | + | |N01AX14 |
− | |[[ | + | | [[Esketamine]] |
|- | |- | ||
| | | | ||
שורה 27,265: | שורה 27,923: | ||
| | | | ||
| | | | ||
− | | | + | |N01AX15 |
− | |[[ | + | | [[Xenon]] |
|- | |- | ||
| | | | ||
שורה 27,272: | שורה 27,930: | ||
| | | | ||
| | | | ||
− | | | + | |N01AX63 |
− | |[[ | + | |[[Nitrous oxide, combinations]] |
|- | |- | ||
| | | | ||
+ | | | ||
+ | |N01B | ||
| | | | ||
| | | | ||
− | + | | [[Anesthetics, local]] | |
− | |||
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N01BA |
− | | | + | | |
− | |[[ | + | |[[Esters of aminobenzoic acid]] |
|- | |- | ||
| | | | ||
שורה 27,293: | שורה 27,951: | ||
| | | | ||
| | | | ||
− | | | + | |N01BA01 |
− | |[[ | + | | [[Metabutethamine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
+ | |N01BA02 | ||
+ | |[[Procaine]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
| | | | ||
− | |[[ | + | | |
+ | |N01BA03 | ||
+ | |[[Tetracaine]] | ||
|- | |- | ||
| | | | ||
שורה 27,307: | שורה 27,972: | ||
| | | | ||
| | | | ||
− | | | + | |N01BA04 |
− | |[[ | + | |[[Chloroprocaine]] |
|- | |- | ||
| | | | ||
שורה 27,314: | שורה 27,979: | ||
| | | | ||
| | | | ||
− | | | + | |N01BA05 |
− | |[[ | + | |[[Benzocaine]] |
|- | |- | ||
| | | | ||
שורה 27,321: | שורה 27,986: | ||
| | | | ||
| | | | ||
− | | | + | |N01BA52 |
− | | [[ | + | | [[Procaine, combinations]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N01BB |
| | | | ||
− | |[[ | + | |[[Amides]] |
|- | |- | ||
| | | | ||
שורה 27,335: | שורה 28,000: | ||
| | | | ||
| | | | ||
− | | | + | |N01BB01 |
− | |[[ | + | |[[Bupivacaine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N01BB02 |
− | |[[ | + | | [[Lidocaine]] |
|- | |- | ||
| | | | ||
שורה 27,349: | שורה 28,014: | ||
| | | | ||
| | | | ||
− | | | + | |N01BB03 |
− | |[[ | + | |[[Mepivacaine]] |
|- | |- | ||
| | | | ||
שורה 27,356: | שורה 28,021: | ||
| | | | ||
| | | | ||
− | | | + | |N01BB04 |
− | |[[ | + | |[[Prilocaine]] |
|- | |- | ||
| | | | ||
שורה 27,363: | שורה 28,028: | ||
| | | | ||
| | | | ||
− | | | + | |N01BB05 |
− | |[[ | + | |[[Butanilicaine]] |
|- | |- | ||
| | | | ||
שורה 27,370: | שורה 28,035: | ||
| | | | ||
| | | | ||
− | | | + | |N01BB06 |
− | |[[ | + | |[[Cinchocaine]] |
|- | |- | ||
| | | | ||
שורה 27,377: | שורה 28,042: | ||
| | | | ||
| | | | ||
− | | | + | |N01BB07 |
− | | [[ | + | |[[Etidocaine]] |
|- | |- | ||
| | | | ||
שורה 27,384: | שורה 28,049: | ||
| | | | ||
| | | | ||
− | | | + | |N01BB08 |
− | |[[ | + | |[[Articaine]] |
|- | |- | ||
| | | | ||
שורה 27,391: | שורה 28,056: | ||
| | | | ||
| | | | ||
− | | | + | |N01BB09 |
− | |[[ | + | |[[Ropivacaine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N01BB10 |
− | |[[ | + | |[[Levobupivacaine]] |
|- | |- | ||
| | | | ||
שורה 27,405: | שורה 28,070: | ||
| | | | ||
| | | | ||
− | | | + | |N01BB20 |
− | |[[ | + | |[[Combinations]] |
|- | |- | ||
| | | | ||
שורה 27,412: | שורה 28,077: | ||
| | | | ||
| | | | ||
− | | | + | |N01BB51 |
− | |[[ | + | |[[Bupivacaine, combinations]] |
|- | |- | ||
| | | | ||
שורה 27,419: | שורה 28,084: | ||
| | | | ||
| | | | ||
− | | | + | |N01BB52 |
− | |[[ | + | |[[Lidocaine, combinations]] |
|- | |- | ||
| | | | ||
שורה 27,426: | שורה 28,091: | ||
| | | | ||
| | | | ||
− | | | + | |N01BB53 |
− | | [[ | + | |[[Mepivacaine, combinations]] |
|- | |- | ||
| | | | ||
שורה 27,433: | שורה 28,098: | ||
| | | | ||
| | | | ||
− | | | + | |N01BB54 |
− | |[[ | + | |[[Prilocaine, combinations]] |
|- | |- | ||
| | | | ||
שורה 27,440: | שורה 28,105: | ||
| | | | ||
| | | | ||
− | | | + | |N01BB57 |
− | |[[ | + | |[[Etidocaine, combinations]] |
|- | |- | ||
| | | | ||
שורה 27,447: | שורה 28,112: | ||
| | | | ||
| | | | ||
− | | | + | |N01BB58 |
− | |[[ | + | |[[Articaine, combinations]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | N01BC |
− | |||
− | |||
− | |||
| | | | ||
− | + | |[[Esters of benzoic acid]] | |
− | |||
− | |||
− | |||
− | | [[ | ||
|- | |- | ||
| | | | ||
שורה 27,468: | שורה 28,126: | ||
| | | | ||
| | | | ||
− | | | + | |N01BC01 |
− | |[[ | + | |[[Cocaine]] |
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
+ | | N01BX | ||
| | | | ||
− | | [[ | + | |[[Other local anesthetics]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N01BX01 |
− | |[[ | + | |[[Ethyl chloride]] |
|- | |- | ||
| | | | ||
שורה 27,489: | שורה 28,147: | ||
| | | | ||
| | | | ||
− | | | + | |N01BX02 |
− | | [[ | + | |[[Dyclonine]] |
|- | |- | ||
| | | | ||
שורה 27,496: | שורה 28,154: | ||
| | | | ||
| | | | ||
− | | | + | |N01BX03 |
− | |[[ | + | |[[Phenol]] |
|- | |- | ||
| | | | ||
שורה 27,503: | שורה 28,161: | ||
| | | | ||
| | | | ||
− | | | + | |N01BX04 |
− | |[[ | + | |[[Capsaicin]] |
|- | |- | ||
+ | | | ||
+ | |N02 | ||
| | | | ||
| | | | ||
| | | | ||
− | + | | [[Analgesics]] | |
− | |||
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
+ | |N02A | ||
| | | | ||
− | |||
− | |||
− | |||
− | |||
| | | | ||
− | + | | [[Opioids]] | |
− | |||
− | |||
− | |||
− | | [[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | N02AA |
| | | | ||
− | |[[ | + | |[[Natural opium alkaloids]] |
|- | |- | ||
| | | | ||
שורה 27,538: | שורה 28,189: | ||
| | | | ||
| | | | ||
− | | | + | |N02AA01 |
− | |[[ | + | |[[Morphine]] |
|- | |- | ||
| | | | ||
שורה 27,545: | שורה 28,196: | ||
| | | | ||
| | | | ||
− | | | + | |N02AA02 |
− | | [[ | + | |[[Opium]] |
|- | |- | ||
| | | | ||
שורה 27,552: | שורה 28,203: | ||
| | | | ||
| | | | ||
− | | | + | |N02AA03 |
− | |[[ | + | |[[Hydromorphone]] |
|- | |- | ||
| | | | ||
שורה 27,559: | שורה 28,210: | ||
| | | | ||
| | | | ||
− | | | + | |N02AA04 |
− | |[[ | + | |[[Nicomorphine]] |
|- | |- | ||
| | | | ||
שורה 27,566: | שורה 28,217: | ||
| | | | ||
| | | | ||
− | | | + | |N02AA05 |
− | |[[ | + | | [[Oxycodone]] |
|- | |- | ||
| | | | ||
שורה 27,573: | שורה 28,224: | ||
| | | | ||
| | | | ||
− | | | + | |N02AA08 |
− | |[[ | + | |[[Dihydrocodeine]] |
|- | |- | ||
| | | | ||
שורה 27,580: | שורה 28,231: | ||
| | | | ||
| | | | ||
− | | | + | |N02AA10 |
− | |[[ | + | |[[Papaveretum]] |
|- | |- | ||
| | | | ||
שורה 27,587: | שורה 28,238: | ||
| | | | ||
| | | | ||
− | | | + | |N02AA51 |
− | |[[ | + | |[[Morphine, combinations]] |
|- | |- | ||
| | | | ||
שורה 27,594: | שורה 28,245: | ||
| | | | ||
| | | | ||
− | | | + | |N02AA55 |
− | |[[ | + | |[[Oxycodone, combinations]] |
|- | |- | ||
| | | | ||
שורה 27,601: | שורה 28,252: | ||
| | | | ||
| | | | ||
− | | | + | |N02AA58 |
− | |[[ | + | |[[Dihydrocodeine, combinations]] |
|- | |- | ||
| | | | ||
שורה 27,608: | שורה 28,259: | ||
| | | | ||
| | | | ||
− | | | + | |N02AA59 |
− | |[[ | + | |[[Codeine, combinations excluding psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 27,615: | שורה 28,266: | ||
| | | | ||
| | | | ||
− | | | + | |N02AA79 |
− | |[[ | + | |[[Codeine, combinations with psycholeptics]] |
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | N02AB | ||
+ | | | ||
+ | |[[Phenylpiperidine derivatives]] | ||
|- | |- | ||
| | | | ||
שורה 27,622: | שורה 28,280: | ||
| | | | ||
| | | | ||
− | | | + | |N02AB01 |
− | |[[ | + | | [[Ketobemidone]] |
|- | |- | ||
| | | | ||
שורה 27,629: | שורה 28,287: | ||
| | | | ||
| | | | ||
− | | | + | |N02AB02 |
− | |[[ | + | |[[Pethidine]] |
|- | |- | ||
| | | | ||
שורה 27,636: | שורה 28,294: | ||
| | | | ||
| | | | ||
− | | | + | |N02AB03 |
− | |[[ | + | |[[Fentanyl]] |
|- | |- | ||
| | | | ||
שורה 27,643: | שורה 28,301: | ||
| | | | ||
| | | | ||
− | | | + | |N02AB52 |
− | |[[ | + | |[[Pethidine, combinations excluding psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 27,650: | שורה 28,308: | ||
| | | | ||
| | | | ||
− | | | + | |N02AB72 |
− | |[[ | + | |[[Pethidine, combinations with psycholeptics]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | N02AC |
| | | | ||
− | |[[ | + | |[[Diphenylpropylamine derivatives]] |
|- | |- | ||
| | | | ||
שורה 27,664: | שורה 28,322: | ||
| | | | ||
| | | | ||
− | | | + | |N02AC01 |
− | |[[ | + | |[[Dextromoramide]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N02AC03 |
− | |[[ | + | | [[Piritramide]] |
|- | |- | ||
| | | | ||
שורה 27,678: | שורה 28,336: | ||
| | | | ||
| | | | ||
− | | | + | |N02AC04 |
− | |[[ | + | |[[Dextropropoxyphene]] |
|- | |- | ||
| | | | ||
שורה 27,685: | שורה 28,343: | ||
| | | | ||
| | | | ||
− | | | + | |N02AC05 |
− | |[[ | + | |[[Bezitramide]] |
|- | |- | ||
| | | | ||
שורה 27,692: | שורה 28,350: | ||
| | | | ||
| | | | ||
− | | | + | |N02AC52 |
− | |[[ | + | |[[Methadone, combinations excluding psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 27,699: | שורה 28,357: | ||
| | | | ||
| | | | ||
− | | | + | |N02AC54 |
− | |[[ | + | |[[Dextropropoxyphene, combinations excluding psycholeptics]] |
|- | |- | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | | | + | | |
− | | [[ | + | |N02AC74 |
+ | |[[Dextropropoxyphene, combinations with psycholeptics]] | ||
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
+ | | N02AD | ||
| | | | ||
− | | [[ | + | |[[Benzomorphan derivatives]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N02AD01 |
− | |[[ | + | |[[Pentazocine]] |
|- | |- | ||
| | | | ||
שורה 27,727: | שורה 28,385: | ||
| | | | ||
| | | | ||
− | | | + | |N02AD02 |
− | |[[ | + | |[[Phenazocine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | N02AE |
− | | | + | | |
− | |[[ | + | |[[ Oripavine derivatives]] |
|- | |- | ||
| | | | ||
שורה 27,741: | שורה 28,399: | ||
| | | | ||
| | | | ||
− | | | + | |N02AE01 |
− | |[[ | + | |[[Buprenorphine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | N02AF |
− | | | + | | |
− | |[[ | + | |[[Morphinan derivatives]] |
|- | |- | ||
| | | | ||
שורה 27,755: | שורה 28,413: | ||
| | | | ||
| | | | ||
− | | | + | |N02AF01 |
− | | [[ | + | |[[Butorphanol]] |
|- | |- | ||
| | | | ||
שורה 27,762: | שורה 28,420: | ||
| | | | ||
| | | | ||
− | | | + | |N02AF02 |
− | |[[ | + | | [[Nalbuphine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | N02AG |
− | | | + | | |
− | |[[ | + | |[[Opioids in combination with antispasmodics]] |
|- | |- | ||
| | | | ||
שורה 27,776: | שורה 28,434: | ||
| | | | ||
| | | | ||
− | | | + | |N02AG01 |
− | |[[Morphine | + | |[[Morphine and antispasmodics]] |
|- | |- | ||
| | | | ||
שורה 27,783: | שורה 28,441: | ||
| | | | ||
| | | | ||
− | | | + | |N02AG02 |
− | |[[ | + | |[[Ketobemidone and antispasmodics]] |
|- | |- | ||
| | | | ||
שורה 27,790: | שורה 28,448: | ||
| | | | ||
| | | | ||
− | | | + | |N02AG03 |
− | |[[ | + | |[[Pethidine and antispasmodics]] |
|- | |- | ||
| | | | ||
שורה 27,797: | שורה 28,455: | ||
| | | | ||
| | | | ||
− | | | + | |N02AG04 |
− | |[[ | + | |[[Hydromorphone and antispasmodics]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N02AX |
− | | | + | | |
− | |[[ | + | |[[Other opioids]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N02AX01 |
− | |[[ | + | |[[Tilidine]] |
|- | |- | ||
| | | | ||
שורה 27,818: | שורה 28,476: | ||
| | | | ||
| | | | ||
− | | | + | |N02AX02 |
− | | [[ | + | | [[Tramadol]] |
|- | |- | ||
| | | | ||
שורה 27,825: | שורה 28,483: | ||
| | | | ||
| | | | ||
− | | | + | |N02AX03 |
− | |[[ | + | | [[Dezocine]] |
|- | |- | ||
| | | | ||
שורה 27,832: | שורה 28,490: | ||
| | | | ||
| | | | ||
− | | | + | |N02AX05 |
− | |[[ | + | |[[Meptazinol]] |
|- | |- | ||
| | | | ||
שורה 27,839: | שורה 28,497: | ||
| | | | ||
| | | | ||
− | | | + | |N02AX06 |
− | |[[ | + | |[[Tapentadol]] |
|- | |- | ||
| | | | ||
שורה 27,846: | שורה 28,504: | ||
| | | | ||
| | | | ||
− | | | + | |N02AX52 |
− | |[[ | + | |[[Tramadol, combinations]] |
|- | |- | ||
| | | | ||
| | | | ||
+ | | N02B | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | | [[Other analgesics and antipyretics]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N02BA |
− | | | + | | |
− | |[[ | + | |[[Salicylic acid and derivatives]] |
|- | |- | ||
| | | | ||
שורה 27,867: | שורה 28,525: | ||
| | | | ||
| | | | ||
− | | | + | |N02BA01 |
− | | [[ | + | |[[Acetylsalicylic acid]] |
|- | |- | ||
| | | | ||
שורה 27,874: | שורה 28,532: | ||
| | | | ||
| | | | ||
− | | | + | |N02BA02 |
− | |[[ | + | |[[Aloxiprin]] |
|- | |- | ||
| | | | ||
שורה 27,881: | שורה 28,539: | ||
| | | | ||
| | | | ||
− | | | + | |N02BA03 |
− | |[[ | + | |[[Choline salicylate]] |
|- | |- | ||
| | | | ||
שורה 27,888: | שורה 28,546: | ||
| | | | ||
| | | | ||
− | | | + | |N02BA04 |
− | |[[ | + | |[[Sodium salicylate]] |
|- | |- | ||
| | | | ||
שורה 27,895: | שורה 28,553: | ||
| | | | ||
| | | | ||
− | | | + | |N02BA05 |
− | |[[ | + | |[[Salicylamide]] |
|- | |- | ||
| | | | ||
שורה 27,902: | שורה 28,560: | ||
| | | | ||
| | | | ||
− | | | + | |N02BA06 |
− | |[[ | + | | [[Salsalate]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N02BA07 |
− | |[[ | + | | [[Ethenzamide]] |
|- | |- | ||
| | | | ||
שורה 27,916: | שורה 28,574: | ||
| | | | ||
| | | | ||
− | | | + | |N02BA08 |
− | |[[ | + | |[[Morpholine salicylate]] |
|- | |- | ||
| | | | ||
שורה 27,923: | שורה 28,581: | ||
| | | | ||
| | | | ||
− | | | + | |N02BA09 |
− | |[[ | + | | [[Dipyrocetyl]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N02BA10 |
− | |[[ | + | |[[Benorilate]] |
|- | |- | ||
| | | | ||
שורה 27,937: | שורה 28,595: | ||
| | | | ||
| | | | ||
− | | | + | |N02BA11 |
− | |[[ | + | | [[Diflunisal]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N02BA12 |
− | |[[ | + | | [[Potassium salicylate]] |
|- | |- | ||
| | | | ||
שורה 27,951: | שורה 28,609: | ||
| | | | ||
| | | | ||
− | | | + | |N02BA14 |
− | |[[ | + | | [[Guacetisal]] |
|- | |- | ||
| | | | ||
שורה 27,958: | שורה 28,616: | ||
| | | | ||
| | | | ||
− | | | + | |N02BA15 |
− | | [[ | + | |[[Carbasalate calcium]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N02BA16 |
− | |[[ | + | |[[Imidazole salicylate]] |
|- | |- | ||
| | | | ||
שורה 27,972: | שורה 28,630: | ||
| | | | ||
| | | | ||
− | | | + | |N02BA51 |
− | |[[ | + | |[[Acetylsalicylic acid, combinations excluding psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 27,979: | שורה 28,637: | ||
| | | | ||
| | | | ||
− | | | + | |N02BA55 |
− | |[[ | + | |[[Salicylamide, combinations excluding psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 27,986: | שורה 28,644: | ||
| | | | ||
| | | | ||
− | | | + | |N02BA57 |
− | |[[ | + | |[[Ethenzamide, combinations excluding psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 27,993: | שורה 28,651: | ||
| | | | ||
| | | | ||
− | | | + | |N02BA59 |
− | |[[ | + | |[[Dipyrocetyl, combinations excluding psycholeptics]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N02BA65 |
− | |[[ | + | |[[Carbasalate calcium combinations excluding psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 28,007: | שורה 28,665: | ||
| | | | ||
| | | | ||
− | | | + | |N02BA71 |
− | |[[ | + | |[[Acetylsalicylic acid, combinations with psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 28,014: | שורה 28,672: | ||
| | | | ||
| | | | ||
− | | | + | |N02BA75 |
− | | [[ | + | |[[Salicylamide, combinations with psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 28,021: | שורה 28,679: | ||
| | | | ||
| | | | ||
− | | | + | |N02BA77 |
− | | [[ | + | |[[Ethenzamide, combinations with psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 28,028: | שורה 28,686: | ||
| | | | ||
| | | | ||
− | | | + | |N02BA79 |
− | |[[ | + | |[[Dipyrocetyl, combinations with psycholeptics]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | N02BB |
− | | | + | | |
− | |[[ | + | |[[Pyrazolones]] |
|- | |- | ||
| | | | ||
שורה 28,042: | שורה 28,700: | ||
| | | | ||
| | | | ||
− | | | + | |N02BB01 |
− | |[[ | + | |[[Phenazone]] |
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | | | + | | |
− | | [[ | + | |N02BB02 |
+ | | [[Metamizole]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N02BB03 |
− | |[[ | + | |[[Aminophenazone]] |
|- | |- | ||
| | | | ||
שורה 28,063: | שורה 28,721: | ||
| | | | ||
| | | | ||
− | | | + | |N02BB04 |
− | |[[ | + | |[[Propyphenazone]] |
|- | |- | ||
| | | | ||
שורה 28,070: | שורה 28,728: | ||
| | | | ||
| | | | ||
− | | | + | |N02BB05 |
− | |[[ | + | |[[Nifenazone]] |
|- | |- | ||
| | | | ||
שורה 28,077: | שורה 28,735: | ||
| | | | ||
| | | | ||
− | | | + | |N02BB51 |
− | |[[ | + | |[[Phenazone, combinations excluding psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 28,084: | שורה 28,742: | ||
| | | | ||
| | | | ||
− | | | + | |N02BB52 |
− | |[[ | + | |[[Metamizole sodium, combinations excluding psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 28,091: | שורה 28,749: | ||
| | | | ||
| | | | ||
− | | | + | |N02BB53 |
− | |[[ | + | |[[Aminophenazone, combinations excluding psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 28,098: | שורה 28,756: | ||
| | | | ||
| | | | ||
− | | | + | |N02BB54 |
− | | [[ | + | |[[Propyphenazone, combinations excluding psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 28,105: | שורה 28,763: | ||
| | | | ||
| | | | ||
− | | | + | |N02BB71 |
− | | [[ | + | |[[Phenazone, combinations with psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 28,112: | שורה 28,770: | ||
| | | | ||
| | | | ||
− | | | + | |N02BB72 |
− | |[[ | + | |[[Metamizole sodium, combinations with psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 28,119: | שורה 28,777: | ||
| | | | ||
| | | | ||
− | | | + | |N02BB73 |
− | | [[ | + | | [[Aminophenazone, combinations with psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 28,126: | שורה 28,784: | ||
| | | | ||
| | | | ||
− | | | + | |N02BB74 |
− | |[[ | + | |[[Propyphenazone, combinations with psycholeptics]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N02BE |
− | | | + | | |
− | | [[ | + | |[[Anilides]] |
|- | |- | ||
| | | | ||
שורה 28,140: | שורה 28,798: | ||
| | | | ||
| | | | ||
− | | | + | |N02BE01 |
− | | [[ | + | |[[Paracetamol]] |
|- | |- | ||
| | | | ||
שורה 28,147: | שורה 28,805: | ||
| | | | ||
| | | | ||
− | | | + | |N02BE03 |
− | | [[ | + | |[[Phenacetin]] |
|- | |- | ||
| | | | ||
שורה 28,154: | שורה 28,812: | ||
| | | | ||
| | | | ||
− | | | + | |N02BE04 |
− | |[[ | + | |[[Bucetin]] |
|- | |- | ||
| | | | ||
שורה 28,161: | שורה 28,819: | ||
| | | | ||
| | | | ||
− | | | + | |N02BE05 |
− | |[[ | + | |[[Propacetamol]] |
|- | |- | ||
| | | | ||
שורה 28,168: | שורה 28,826: | ||
| | | | ||
| | | | ||
− | | | + | |N02BE51 |
− | |[[ | + | |[[Paracetamol, combinations excluding psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 28,175: | שורה 28,833: | ||
| | | | ||
| | | | ||
− | | | + | |N02BE53 |
− | |[[ | + | |[[Phenacetin, combinations excluding psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 28,182: | שורה 28,840: | ||
| | | | ||
| | | | ||
− | | | + | |N02BE54 |
− | |[[ | + | |[[Bucetin, combinations excluding psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 28,189: | שורה 28,847: | ||
| | | | ||
| | | | ||
− | | | + | |N02BE71 |
− | |[[ | + | |[[Paracetamol, combinations with psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 28,196: | שורה 28,854: | ||
| | | | ||
| | | | ||
− | | | + | |N02BE73 |
− | |[[ | + | |[[Phenacetin, combinations with psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 28,203: | שורה 28,861: | ||
| | | | ||
| | | | ||
− | | | + | |N02BE74 |
− | |[[ | + | |[[Bucetin, combinations with psycholeptics]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | N02BG |
− | | | + | | |
− | |[[ | + | |[[Other analgesics and antipyretics]] |
|- | |- | ||
| | | | ||
שורה 28,217: | שורה 28,875: | ||
| | | | ||
| | | | ||
− | | | + | |N02BG02 |
− | |[[ | + | |[[Rimazolium]] |
|- | |- | ||
| | | | ||
שורה 28,224: | שורה 28,882: | ||
| | | | ||
| | | | ||
− | | | + | |N02BG03 |
− | |[[ | + | |[[Glafenine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N02BG04 |
− | |[[ | + | |[[Floctafenine]] |
|- | |- | ||
| | | | ||
שורה 28,238: | שורה 28,896: | ||
| | | | ||
| | | | ||
− | | | + | |N02BG05 |
− | |[[ | + | |[[Viminol]] |
|- | |- | ||
| | | | ||
שורה 28,245: | שורה 28,903: | ||
| | | | ||
| | | | ||
− | | | + | |N02BG06 |
− | | [[ | + | | [[Nefopam]] |
|- | |- | ||
| | | | ||
שורה 28,252: | שורה 28,910: | ||
| | | | ||
| | | | ||
− | | | + | |N02BG07 |
− | |[[ | + | | [[Flupirtine]] |
|- | |- | ||
| | | | ||
שורה 28,259: | שורה 28,917: | ||
| | | | ||
| | | | ||
− | | | + | |N02BG08 |
− | |[[ | + | | [[Ziconotide]] |
|- | |- | ||
| | | | ||
שורה 28,266: | שורה 28,924: | ||
| | | | ||
| | | | ||
− | | | + | |N02BG09 |
− | |[[ | + | |[[Methoxyflurane]] |
|- | |- | ||
| | | | ||
שורה 28,273: | שורה 28,931: | ||
| | | | ||
| | | | ||
− | | | + | |N02BG10 |
− | |[[ | + | |[[Nabiximols]] |
|- | |- | ||
| | | | ||
| | | | ||
+ | | N02C | ||
| | | | ||
− | | | + | | |
− | + | | [[Antimigraine preparations]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N02CA |
− | | | + | | |
− | |[[ | + | |[[Ergot alkaloids]] |
|- | |- | ||
| | | | ||
שורה 28,294: | שורה 28,952: | ||
| | | | ||
| | | | ||
− | | | + | |N02CA01 |
− | |[[ | + | |[[Dihydroergotamine]] |
|- | |- | ||
| | | | ||
שורה 28,301: | שורה 28,959: | ||
| | | | ||
| | | | ||
− | | | + | |N02CA02 |
− | |[[ | + | |[[Ergotamine]] |
|- | |- | ||
| | | | ||
שורה 28,308: | שורה 28,966: | ||
| | | | ||
| | | | ||
− | | | + | |N02CA04 |
− | |[[ | + | |[[Methysergide]] |
|- | |- | ||
| | | | ||
שורה 28,315: | שורה 28,973: | ||
| | | | ||
| | | | ||
− | | | + | |N02CA07 |
− | | [[ | + | |[[Lisuride]] |
|- | |- | ||
| | | | ||
שורה 28,322: | שורה 28,980: | ||
| | | | ||
| | | | ||
− | | | + | |N02CA51 |
− | |[[ | + | |[[Dihydroergotamine, combinations]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N02CA52 |
− | |[[ | + | | [[Ergotamine, combinations excluding psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 28,336: | שורה 28,994: | ||
| | | | ||
| | | | ||
− | | | + | |N02CA72 |
− | |[[ | + | |[[Ergotamine, combinations with psycholeptics]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | N02CB |
− | | | + | | |
− | |[[ | + | |[[Corticosteroid derivatives]] |
|- | |- | ||
| | | | ||
שורה 28,350: | שורה 29,008: | ||
| | | | ||
| | | | ||
− | | | + | |N02CB01 |
− | |[[ | + | |[[Flumedroxone]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N02CC |
− | | | + | | |
− | |[[ | + | |[[Selective serotonin (5-HT1) agonists]] |
|- | |- | ||
| | | | ||
שורה 28,364: | שורה 29,022: | ||
| | | | ||
| | | | ||
− | | | + | |N02CC01 |
− | |[[ | + | |[[Sumatriptan]] |
|- | |- | ||
| | | | ||
שורה 28,371: | שורה 29,029: | ||
| | | | ||
| | | | ||
− | | | + | |N02CC02 |
− | |[[ | + | |[[Naratriptan]] |
|- | |- | ||
| | | | ||
שורה 28,378: | שורה 29,036: | ||
| | | | ||
| | | | ||
− | | | + | |N02CC03 |
− | |[[ | + | |[[Zolmitriptan]] |
|- | |- | ||
| | | | ||
שורה 28,385: | שורה 29,043: | ||
| | | | ||
| | | | ||
− | | | + | |N02CC04 |
− | |[[ | + | |[[Rizatriptan]] |
|- | |- | ||
| | | | ||
שורה 28,392: | שורה 29,050: | ||
| | | | ||
| | | | ||
− | | | + | |N02CC05 |
− | |[[ | + | |[[Almotriptan]] |
|- | |- | ||
| | | | ||
שורה 28,399: | שורה 29,057: | ||
| | | | ||
| | | | ||
− | | | + | |N02CC06 |
− | |[[ | + | |[[Eletriptan]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N02CC07 |
− | |[[ | + | |[[Frovatriptan]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N02CX |
− | |||
− | |||
− | |||
| | | | ||
− | + | |[[Other antimigraine preparations]] | |
− | |||
− | |||
− | |||
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 28,427: | שורה 29,078: | ||
| | | | ||
| | | | ||
− | | | + | |N02CX01 |
− | |[[ | + | | [[Pizotifen]] |
|- | |- | ||
| | | | ||
שורה 28,434: | שורה 29,085: | ||
| | | | ||
| | | | ||
− | | | + | |N02CX02 |
− | |[[ | + | |[[Clonidine]] |
|- | |- | ||
| | | | ||
שורה 28,441: | שורה 29,092: | ||
| | | | ||
| | | | ||
− | | | + | |N02CX03 |
− | | [[ | + | |[[Iprazochrome]] |
|- | |- | ||
| | | | ||
שורה 28,448: | שורה 29,099: | ||
| | | | ||
| | | | ||
− | | | + | |N02CX05 |
− | | [[ | + | |[[Dimetotiazine]] |
|- | |- | ||
| | | | ||
שורה 28,455: | שורה 29,106: | ||
| | | | ||
| | | | ||
− | | | + | |N02CX06 |
− | | [[ | + | |[[Oxetorone]] |
|- | |- | ||
| | | | ||
+ | |N03 | ||
| | | | ||
| | | | ||
− | |||
− | |||
− | |||
− | |||
| | | | ||
− | + | | [[Antiepileptics]] | |
− | |||
− | |||
− | |||
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
− | | | + | | N03A |
| | | | ||
| | | | ||
− | | [[ | + | | [[Antiepileptics]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | N03AA |
| | | | ||
− | |[[ | + | |[[Barbiturates and derivatives]] |
|- | |- | ||
| | | | ||
שורה 28,490: | שורה 29,134: | ||
| | | | ||
| | | | ||
− | | | + | |N03AA01 |
− | |[[ | + | |[[Methylphenobarbital]] |
|- | |- | ||
| | | | ||
שורה 28,497: | שורה 29,141: | ||
| | | | ||
| | | | ||
− | | | + | |N03AA02 |
− | |[[ | + | |[[Phenobarbital]] |
|- | |- | ||
| | | | ||
שורה 28,504: | שורה 29,148: | ||
| | | | ||
| | | | ||
− | | | + | |N03AA03 |
− | |[[ | + | |[[Primidone]] |
|- | |- | ||
| | | | ||
שורה 28,511: | שורה 29,155: | ||
| | | | ||
| | | | ||
− | | | + | |N03AA04 |
− | |[[ | + | |[[Barbexaclone]] |
|- | |- | ||
| | | | ||
שורה 28,518: | שורה 29,162: | ||
| | | | ||
| | | | ||
− | | | + | |N03AA30 |
− | |[[ | + | |[[Metharbital]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N03AB |
− | | | + | | |
− | | [[ | + | |[[Hydantoin derivatives]] |
|- | |- | ||
| | | | ||
שורה 28,532: | שורה 29,176: | ||
| | | | ||
| | | | ||
− | | | + | |N03AB01 |
− | |[[ | + | |[[Ethotoin]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N03AB02 |
− | |[[ | + | | [[Phenytoin]] |
|- | |- | ||
| | | | ||
שורה 28,546: | שורה 29,190: | ||
| | | | ||
| | | | ||
− | | | + | |03AB03 |
− | |[[ | + | |[[Amino(diphenylhydantoin) valeric acid]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N03AB04 |
− | |[[ | + | |[[Mephenytoin]] |
|- | |- | ||
| | | | ||
שורה 28,560: | שורה 29,204: | ||
| | | | ||
| | | | ||
− | | | + | |N03AB05 |
− | |[[ | + | |[[Fosphenytoin]] |
|- | |- | ||
| | | | ||
שורה 28,567: | שורה 29,211: | ||
| | | | ||
| | | | ||
− | | | + | |N03AB52 |
− | |[[ | + | |[[Phenytoin, combinations]] |
|- | |- | ||
| | | | ||
שורה 28,574: | שורה 29,218: | ||
| | | | ||
| | | | ||
− | | | + | |N03AB54 |
− | |[[ | + | | [[Mephenytoin, combinations]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | N03AC |
− | | | + | | |
− | |[[ | + | |[[Oxazolidine derivatives]] |
|- | |- | ||
| | | | ||
שורה 28,588: | שורה 29,232: | ||
| | | | ||
| | | | ||
− | | | + | |N03AC01 |
− | |[[ | + | | [[Paramethadione]] |
|- | |- | ||
| | | | ||
שורה 28,595: | שורה 29,239: | ||
| | | | ||
| | | | ||
− | | | + | |N03AC02 |
− | |[[ | + | |[[Trimethadione]] |
|- | |- | ||
| | | | ||
שורה 28,602: | שורה 29,246: | ||
| | | | ||
| | | | ||
− | | | + | |N03AC03 |
− | |[[ | + | |[[Ethadione]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | N03AD |
| | | | ||
− | |[[ | + | |[[Succinimide derivatives]] |
|- | |- | ||
| | | | ||
שורה 28,616: | שורה 29,260: | ||
| | | | ||
| | | | ||
− | | | + | |N03AD01 |
− | | [[ | + | |[[Ethosuximide]] |
|- | |- | ||
| | | | ||
שורה 28,623: | שורה 29,267: | ||
| | | | ||
| | | | ||
− | | | + | |N03AD02 |
− | |[[ | + | |[[Phensuximide]] |
|- | |- | ||
| | | | ||
שורה 28,630: | שורה 29,274: | ||
| | | | ||
| | | | ||
− | | | + | |N03AD03 |
− | |[[ | + | |[[Mesuximide]] |
|- | |- | ||
| | | | ||
שורה 28,637: | שורה 29,281: | ||
| | | | ||
| | | | ||
− | | | + | |N03AD51 |
− | |[[ | + | |[[Ethosuximide, combinations]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N03AE |
− | | | + | | |
− | |[[ | + | |[[Benzodiazepine derivatives]] |
|- | |- | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | | | + | | |
− | | [[ | + | |N03AE01 |
+ | | [[Clonazepam]] | ||
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
+ | | N03AF | ||
| | | | ||
− | | [[ | + | |[[Carboxamide derivatives]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N03AF01 |
− | |[[ | + | | [[Carbamazepine]] |
|- | |- | ||
| | | | ||
שורה 28,672: | שורה 29,316: | ||
| | | | ||
| | | | ||
− | | | + | |N03AF02 |
− | |[[ | + | |[[Oxcarbazepine]] |
|- | |- | ||
| | | | ||
שורה 28,679: | שורה 29,323: | ||
| | | | ||
| | | | ||
− | | | + | |N03AF03 |
− | |[[ | + | |[[Rufinamide]] |
|- | |- | ||
| | | | ||
שורה 28,686: | שורה 29,330: | ||
| | | | ||
| | | | ||
− | | | + | |N03AF04 |
− | |[[ | + | |[[Eslicarbazepine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N03AG |
− | | | + | | |
− | |[[ | + | |[[Fatty acid derivatives]] |
|- | |- | ||
| | | | ||
שורה 28,700: | שורה 29,344: | ||
| | | | ||
| | | | ||
− | | | + | |N03AG01 |
− | |[[ | + | |[[Valproic acid]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N03AG02 |
− | |[[ | + | | [[Valpromide]] |
|- | |- | ||
| | | | ||
שורה 28,714: | שורה 29,358: | ||
| | | | ||
| | | | ||
− | | | + | |N03AG03 |
− | |[[ | + | | [[Aminobutyric acid]] |
|- | |- | ||
| | | | ||
שורה 28,721: | שורה 29,365: | ||
| | | | ||
| | | | ||
− | | | + | |N03AG04 |
− | | [[ | + | | [[Vigabatrin]] |
|- | |- | ||
| | | | ||
שורה 28,728: | שורה 29,372: | ||
| | | | ||
| | | | ||
− | | | + | |N03AG05 |
− | |[[ | + | |[[Progabide]] |
|- | |- | ||
| | | | ||
שורה 28,735: | שורה 29,379: | ||
| | | | ||
| | | | ||
− | | | + | |N03AG06 |
− | |[[ | + | |[[Tiagabine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | N03AX |
− | | | + | | |
− | |[[ | + | |[[Other antiepileptics]] |
|- | |- | ||
| | | | ||
שורה 28,749: | שורה 29,393: | ||
| | | | ||
| | | | ||
− | | | + | |N03AX03 |
− | |[[ | + | |[[Sultiame]] |
|- | |- | ||
| | | | ||
שורה 28,756: | שורה 29,400: | ||
| | | | ||
| | | | ||
− | | | + | |N03AX07 |
− | | [[ | + | | [[Phenacemide]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N03AX09 |
− | |[[ | + | | [[Lamotrigine]] |
|- | |- | ||
| | | | ||
שורה 28,770: | שורה 29,414: | ||
| | | | ||
| | | | ||
− | | | + | |N03AX10 |
− | | [[ | + | |[[Felbamate]] |
|- | |- | ||
| | | | ||
שורה 28,777: | שורה 29,421: | ||
| | | | ||
| | | | ||
− | | | + | |N03AX11 |
− | |[[ | + | |[[Topiramate]] |
|- | |- | ||
| | | | ||
שורה 28,784: | שורה 29,428: | ||
| | | | ||
| | | | ||
− | | | + | |N03AX12 |
− | |[[ | + | |[[Gabapentin]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N03AX13 |
− | |[[ | + | |[[Pheneturide]] |
|- | |- | ||
| | | | ||
שורה 28,798: | שורה 29,442: | ||
| | | | ||
| | | | ||
− | | | + | |N03AX14 |
− | |[[ | + | |[[Levetiracetam]] |
|- | |- | ||
| | | | ||
שורה 28,805: | שורה 29,449: | ||
| | | | ||
| | | | ||
− | | | + | |N03AX15 |
− | |[[ | + | |[[Zonisamide]] |
|- | |- | ||
| | | | ||
שורה 28,812: | שורה 29,456: | ||
| | | | ||
| | | | ||
− | | | + | |N03AX16 |
− | |[[ | + | |[[Pregabalin]] |
|- | |- | ||
| | | | ||
שורה 28,819: | שורה 29,463: | ||
| | | | ||
| | | | ||
− | | | + | |N03AX17 |
− | |[[ | + | | [[Stiripentol]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N03AX18 |
− | |[[ | + | | [[Lacosamide]] |
|- | |- | ||
| | | | ||
שורה 28,833: | שורה 29,477: | ||
| | | | ||
| | | | ||
− | | | + | |N03AX19 |
− | | [[ | + | |[[Carisbamate]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N03AX21 |
− | |[[ | + | |[[Retigabine]] |
|- | |- | ||
| | | | ||
שורה 28,847: | שורה 29,491: | ||
| | | | ||
| | | | ||
− | | | + | |N03AX22 |
− | | [[ | + | |[[Perampanel]] |
|- | |- | ||
| | | | ||
שורה 28,854: | שורה 29,498: | ||
| | | | ||
| | | | ||
− | | | + | |N03AX30 |
− | |[[ | + | |[[Beclamide]] |
|- | |- | ||
+ | | | ||
+ | |N04 | ||
| | | | ||
| | | | ||
| | | | ||
− | + | |[[Anti-parkinson drugs]] | |
− | |||
− | |[[ | ||
|- | |- | ||
| | | | ||
+ | | | ||
+ | | N04A | ||
| | | | ||
| | | | ||
− | + | | [[Anticholinergic agents]] | |
− | |||
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N04AA |
| | | | ||
− | |[[ | + | |[[Tertiary amines]] |
|- | |- | ||
| | | | ||
שורה 28,882: | שורה 29,526: | ||
| | | | ||
| | | | ||
− | | | + | |N04AA01 |
− | |[[ | + | |[[Trihexyphenidyl]] |
|- | |- | ||
| | | | ||
שורה 28,889: | שורה 29,533: | ||
| | | | ||
| | | | ||
− | | | + | |N04AA02 |
− | | [[ | + | |[[Biperiden]] |
|- | |- | ||
| | | | ||
שורה 28,896: | שורה 29,540: | ||
| | | | ||
| | | | ||
− | | | + | |N04AA03 |
− | | [[ | + | |[[Metixene]] |
|- | |- | ||
| | | | ||
שורה 28,903: | שורה 29,547: | ||
| | | | ||
| | | | ||
− | | | + | |N04AA04 |
− | | [[ | + | |[[Procyclidine]] |
|- | |- | ||
| | | | ||
שורה 28,910: | שורה 29,554: | ||
| | | | ||
| | | | ||
− | | | + | |N04AA05 |
− | |[[ | + | |[[Profenamine]] |
|- | |- | ||
| | | | ||
שורה 28,917: | שורה 29,561: | ||
| | | | ||
| | | | ||
− | | | + | |N04AA08 |
− | |[[ | + | |[[Dexetimide]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N04AA09 |
− | |[[ | + | |[[Phenglutarimide]] |
|- | |- | ||
| | | | ||
שורה 28,931: | שורה 29,575: | ||
| | | | ||
| | | | ||
− | | | + | |N04AA10 |
− | |[[ | + | | [[Mazaticol]] |
|- | |- | ||
| | | | ||
שורה 28,938: | שורה 29,582: | ||
| | | | ||
| | | | ||
− | | | + | |N04AA11 |
− | | [[ | + | | [[Bornaprine]] |
|- | |- | ||
| | | | ||
שורה 28,945: | שורה 29,589: | ||
| | | | ||
| | | | ||
− | | | + | |N04AA12 |
− | | [[ | + | |[[Tropatepine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N04AB |
− | | | + | | |
− | |[[ | + | |[[Ethers chemically close to antihistamines]] |
|- | |- | ||
| | | | ||
שורה 28,959: | שורה 29,603: | ||
| | | | ||
| | | | ||
− | | | + | |N04AB01 |
− | |[[ | + | | [[Etanautine]] |
|- | |- | ||
| | | | ||
שורה 28,966: | שורה 29,610: | ||
| | | | ||
| | | | ||
− | | | + | |N04AB02 |
− | |[[ | + | |[[Orphenadrine (chloride)]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N04AC |
− | | | + | | |
− | |[[ | + | |[[Ethers of tropine or tropine derivatives]] |
|- | |- | ||
| | | | ||
שורה 28,980: | שורה 29,624: | ||
| | | | ||
| | | | ||
− | | | + | |N04AC01 |
− | |[[ | + | |[[Benzatropine]] |
|- | |- | ||
| | | | ||
שורה 28,987: | שורה 29,631: | ||
| | | | ||
| | | | ||
− | | | + | |N04AC30 |
− | |[[ | + | | [[Etybenzatropine]] |
|- | |- | ||
| | | | ||
| | | | ||
+ | | N04B | ||
| | | | ||
− | | | + | | |
− | + | | [[Dopaminergic agents]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N04BA |
− | | | + | | |
− | | [[ | + | |[[Dopa and dopa derivatives]] |
|- | |- | ||
| | | | ||
שורה 29,008: | שורה 29,652: | ||
| | | | ||
| | | | ||
− | | | + | |N04BA01 |
− | | [[ | + | | [[Levodopa]] |
|- | |- | ||
| | | | ||
שורה 29,015: | שורה 29,659: | ||
| | | | ||
| | | | ||
− | | | + | |N04BA02 |
− | |[[ | + | |[[Levodopa and decarboxylase inhibitor]] |
|- | |- | ||
| | | | ||
שורה 29,022: | שורה 29,666: | ||
| | | | ||
| | | | ||
− | | | + | |N04BA03 |
− | |[[ | + | |[[Levodopa, decarboxylase inhibitor and COMT inhibitor]] |
|- | |- | ||
| | | | ||
שורה 29,029: | שורה 29,673: | ||
| | | | ||
| | | | ||
− | | | + | |N04BA04 |
− | |[[ | + | |[[Melevodopa]] |
|- | |- | ||
| | | | ||
שורה 29,036: | שורה 29,680: | ||
| | | | ||
| | | | ||
− | | | + | |N04BA05 |
− | |[[ | + | |[[Melevodopa and decarboxylase inhibitor]] |
|- | |- | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | | | + | | |
− | |[[ | + | |N04BA06 |
+ | | [[Etilevodopa and decarboxylase inhibitor]] | ||
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
+ | |N04BB | ||
| | | | ||
− | | [[ | + | |[[Adamantane derivatives]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
+ | |N04BB01 | ||
+ | |[[Amantadine]] | ||
+ | |- | ||
| | | | ||
− | |||
− | |||
| | | | ||
| | | | ||
+ | |N04BC | ||
| | | | ||
− | + | |[[Dopamine agonists]] | |
− | |||
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 29,071: | שורה 29,715: | ||
| | | | ||
| | | | ||
− | | | + | |N04BC01 |
− | |[[ | + | |[[Bromocriptine]] |
|- | |- | ||
| | | | ||
שורה 29,078: | שורה 29,722: | ||
| | | | ||
| | | | ||
− | | | + | |N04BC02 |
− | |[[ | + | | [[Pergolide]] |
|- | |- | ||
| | | | ||
שורה 29,085: | שורה 29,729: | ||
| | | | ||
| | | | ||
− | | | + | |N04BC03 |
− | |[[ | + | |[[Dihydroergocryptine mesylate]] |
|- | |- | ||
| | | | ||
שורה 29,092: | שורה 29,736: | ||
| | | | ||
| | | | ||
− | | | + | |N04BC04 |
− | |[[ | + | | [[Ropinirole]] |
|- | |- | ||
| | | | ||
שורה 29,099: | שורה 29,743: | ||
| | | | ||
| | | | ||
− | | | + | |N04BC05 |
− | |[[ | + | |[[Pramipexole]] |
|- | |- | ||
| | | | ||
שורה 29,106: | שורה 29,750: | ||
| | | | ||
| | | | ||
− | | | + | |N04BC06 |
− | |[[ | + | |[[Cabergoline]] |
|- | |- | ||
| | | | ||
שורה 29,113: | שורה 29,757: | ||
| | | | ||
| | | | ||
− | | | + | |N04BC07 |
− | | [[ | + | |[[Apomorphine]] |
|- | |- | ||
| | | | ||
שורה 29,120: | שורה 29,764: | ||
| | | | ||
| | | | ||
− | | | + | |N04BC08 |
− | | [[ | + | |[[Piribedil]] |
|- | |- | ||
| | | | ||
שורה 29,127: | שורה 29,771: | ||
| | | | ||
| | | | ||
− | | | + | |N04BC09 |
− | |[[ | + | |[[Rotigotine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N04BD |
| | | | ||
− | |[[ | + | |[[Monoamine oxidase B inhibitors]] |
|- | |- | ||
| | | | ||
שורה 29,141: | שורה 29,785: | ||
| | | | ||
| | | | ||
− | | | + | |N04BD01 |
− | | [[ | + | |[[Selegiline]] |
|- | |- | ||
| | | | ||
שורה 29,148: | שורה 29,792: | ||
| | | | ||
| | | | ||
− | | | + | |N04BD02 |
− | |[[ | + | |[[Rasagiline]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N04BX |
| | | | ||
− | |[[ | + | |[[Other dopaminergic agents]] |
|- | |- | ||
| | | | ||
שורה 29,162: | שורה 29,806: | ||
| | | | ||
| | | | ||
− | | | + | |N04BX01 |
− | |[[ | + | |[[Tolcapone]] |
|- | |- | ||
| | | | ||
שורה 29,169: | שורה 29,813: | ||
| | | | ||
| | | | ||
− | | | + | |N04BX02 |
− | | [[ | + | |[[Entacapone]] |
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | | | + | | |
− | | [[ | + | |N04BX03 |
+ | |[[Budipine]] | ||
|- | |- | ||
| | | | ||
+ | |N05 | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | | [[Psycholeptics]] |
|- | |- | ||
| | | | ||
| | | | ||
+ | |N05A | ||
| | | | ||
− | | | + | | |
− | + | | [[Antipsychotics]] | |
− | | [[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N05AA |
− | | | + | | |
− | |[[ | + | |[[Phenothiazines with aliphatic side-chain]] |
|- | |- | ||
| | | | ||
שורה 29,204: | שורה 29,848: | ||
| | | | ||
| | | | ||
− | | | + | |N05AA01 |
− | |[[ | + | |[[Chlorpromazine]] |
|- | |- | ||
| | | | ||
שורה 29,211: | שורה 29,855: | ||
| | | | ||
| | | | ||
− | | | + | |N05AA02 |
− | |[[ | + | |[[Levomepromazine]] |
|- | |- | ||
| | | | ||
שורה 29,218: | שורה 29,862: | ||
| | | | ||
| | | | ||
− | | | + | |N05AA03 |
− | |[[ | + | |[[Promazine]] |
|- | |- | ||
| | | | ||
שורה 29,225: | שורה 29,869: | ||
| | | | ||
| | | | ||
− | | | + | |N05AA04 |
− | | [[ | + | |[[Acepromazine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
+ | |N05AA05 | ||
+ | |[[Triflupromazine]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
| | | | ||
− | |[[ | + | | |
+ | |N05AA06 | ||
+ | |[[Cyamemazine]] | ||
|- | |- | ||
| | | | ||
שורה 29,239: | שורה 29,890: | ||
| | | | ||
| | | | ||
− | | | + | |N05AA07 |
− | |[[ | + | |[[Chlorproethazine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N05AB |
| | | | ||
− | |[[ | + | |[[Phenothiazines with piperazine structure]] |
|- | |- | ||
| | | | ||
שורה 29,253: | שורה 29,904: | ||
| | | | ||
| | | | ||
− | | | + | |N05AB01 |
− | |[[ | + | |[[Dixyrazine]] |
|- | |- | ||
| | | | ||
שורה 29,260: | שורה 29,911: | ||
| | | | ||
| | | | ||
− | | | + | |N05AB02 |
− | | [[ | + | |[[Fluphenazine]] |
|- | |- | ||
| | | | ||
שורה 29,267: | שורה 29,918: | ||
| | | | ||
| | | | ||
− | | | + | |N05AB03 |
− | |[[ | + | |[[Perphenazine]] |
|- | |- | ||
| | | | ||
שורה 29,274: | שורה 29,925: | ||
| | | | ||
| | | | ||
− | | | + | |N05AB04 |
− | | [[ | + | |[[Prochlorperazine]] |
|- | |- | ||
| | | | ||
שורה 29,281: | שורה 29,932: | ||
| | | | ||
| | | | ||
− | | | + | |N05AB05 |
− | |[[ | + | |[[Thiopropazate]] |
|- | |- | ||
| | | | ||
שורה 29,288: | שורה 29,939: | ||
| | | | ||
| | | | ||
− | | | + | |N05AB06 |
− | |[[ | + | |[[Trifluoperazine]] |
|- | |- | ||
| | | | ||
שורה 29,295: | שורה 29,946: | ||
| | | | ||
| | | | ||
− | | | + | |N05AB07 |
− | |[[ | + | |[[Acetophenazine]] |
|- | |- | ||
| | | | ||
שורה 29,302: | שורה 29,953: | ||
| | | | ||
| | | | ||
− | | | + | |N05AB08 |
− | |[[ | + | | [[Thioproperazine]] |
|- | |- | ||
| | | | ||
שורה 29,309: | שורה 29,960: | ||
| | | | ||
| | | | ||
− | | | + | |N05AB09 |
− | |[[ | + | |[[Butaperazine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
+ | |N05AB10 | ||
+ | |[[Perazine]] | ||
+ | |- | ||
| | | | ||
− | |||
− | |||
| | | | ||
| | | | ||
+ | |N05AC | ||
| | | | ||
− | + | |[[Phenothiazines with piperidine structure]] | |
− | |||
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 29,330: | שורה 29,981: | ||
| | | | ||
| | | | ||
− | | | + | |N05AC01 |
− | |[[ | + | | [[Periciazine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N05AC02 |
− | |[[ | + | | [[Thioridazine]] |
|- | |- | ||
| | | | ||
שורה 29,344: | שורה 29,995: | ||
| | | | ||
| | | | ||
− | | | + | |N05AC03 |
− | |[[ | + | |[[Mesoridazine]] |
|- | |- | ||
| | | | ||
שורה 29,351: | שורה 30,002: | ||
| | | | ||
| | | | ||
− | | | + | |N05AC04 |
− | |[[ | + | |[[Pipotiazine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N05AD |
− | | | + | | |
− | |[[ | + | |[[Butyrophenone derivatives]] |
|- | |- | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | | | + | | |
− | | [[ | + | |N05AD01 |
+ | |[[Haloperidol]] | ||
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | | | + | | |
− | | [[ | + | |N05AD02 |
+ | |[[Trifluperidol]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N05AD03 |
− | |[[ | + | |[[Melperone]] |
|- | |- | ||
| | | | ||
שורה 29,386: | שורה 30,037: | ||
| | | | ||
| | | | ||
− | | | + | |N05AD04 |
− | |[[ | + | |[[Moperone]] |
|- | |- | ||
| | | | ||
שורה 29,393: | שורה 30,044: | ||
| | | | ||
| | | | ||
− | | | + | |N05AD05 |
− | |[[ | + | |[[Pipamperone]] |
|- | |- | ||
| | | | ||
שורה 29,400: | שורה 30,051: | ||
| | | | ||
| | | | ||
− | | | + | |N05AD06 |
− | |[[ | + | |[[Bromperidol]] |
|- | |- | ||
| | | | ||
שורה 29,407: | שורה 30,058: | ||
| | | | ||
| | | | ||
− | | | + | |N05AD07 |
− | |[[ | + | | [[Benperidol]] |
|- | |- | ||
| | | | ||
שורה 29,414: | שורה 30,065: | ||
| | | | ||
| | | | ||
− | | | + | |N05AD08 |
− | |[[ | + | |[[Droperidol]] |
|- | |- | ||
| | | | ||
שורה 29,421: | שורה 30,072: | ||
| | | | ||
| | | | ||
− | | | + | |N05AD09 |
− | |[[ | + | |[[Fluanisone]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N05AE |
− | | | + | | |
− | |[[ | + | |[[Indole derivatives]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N05AE01 |
− | |[[ | + | |[[Oxypertine]] |
|- | |- | ||
| | | | ||
שורה 29,442: | שורה 30,093: | ||
| | | | ||
| | | | ||
− | | | + | |N05AE02 |
− | |[[ | + | |[[Molindone]] |
|- | |- | ||
| | | | ||
שורה 29,449: | שורה 30,100: | ||
| | | | ||
| | | | ||
− | | | + | |N05AE03 |
− | |[[ | + | |[[Sertindole]] |
|- | |- | ||
| | | | ||
שורה 29,456: | שורה 30,107: | ||
| | | | ||
| | | | ||
− | | | + | |N05AE04 |
− | |[[ | + | |[[Ziprasidone]] |
|- | |- | ||
| | | | ||
שורה 29,463: | שורה 30,114: | ||
| | | | ||
| | | | ||
− | | | + | |N05AE05 |
− | |[[ | + | |[[Lurasidone]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N05AF |
− | | | + | | |
− | |[[ | + | |[[Thioxanthene derivative]] |
|- | |- | ||
| | | | ||
שורה 29,477: | שורה 30,128: | ||
| | | | ||
| | | | ||
− | | | + | |N05AF01 |
− | |[[ | + | |[[Flupentixol]] |
|- | |- | ||
| | | | ||
שורה 29,484: | שורה 30,135: | ||
| | | | ||
| | | | ||
− | | | + | |N05AF02 |
− | |[[ | + | |[[Clopenthixol]] |
|- | |- | ||
| | | | ||
שורה 29,491: | שורה 30,142: | ||
| | | | ||
| | | | ||
− | | | + | |N05AF03 |
− | | [[ | + | | [[Chlorprothixene]] |
|- | |- | ||
| | | | ||
שורה 29,498: | שורה 30,149: | ||
| | | | ||
| | | | ||
− | | | + | |N05AF04 |
− | |[[ | + | | [[Thiothixene]] |
|- | |- | ||
| | | | ||
שורה 29,505: | שורה 30,156: | ||
| | | | ||
| | | | ||
− | | | + | |N05AF05 |
− | |[[ | + | | [[Zuclopenthixol]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N05AG |
| | | | ||
− | |[[ | + | |[[Diphenylbutylpiperidine derivatives]] |
|- | |- | ||
| | | | ||
שורה 29,519: | שורה 30,170: | ||
| | | | ||
| | | | ||
− | | | + | |N05AG01 |
− | | [[ | + | |[[Fluspirilene]] |
|- | |- | ||
| | | | ||
שורה 29,526: | שורה 30,177: | ||
| | | | ||
| | | | ||
− | | | + | |N05AG02 |
− | | [[ | + | |[[Pimozide]] |
|- | |- | ||
| | | | ||
שורה 29,533: | שורה 30,184: | ||
| | | | ||
| | | | ||
− | | | + | |N05AG03 |
− | |[[ | + | | [[Penfluridol]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N05AH |
− | | | + | | |
− | |[[ | + | |[[Diazepines, oxazepines, thiazepines and oxepines]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N05AH01 |
− | |[[ | + | | [[Loxapine]] |
|- | |- | ||
| | | | ||
שורה 29,554: | שורה 30,205: | ||
| | | | ||
| | | | ||
− | | | + | |N05AH02 |
− | |[[ | + | |[[Clozapine]] |
|- | |- | ||
| | | | ||
שורה 29,561: | שורה 30,212: | ||
| | | | ||
| | | | ||
− | | | + | |N05AH03 |
− | |[[ | + | |[[Olanzapine]] |
|- | |- | ||
| | | | ||
שורה 29,568: | שורה 30,219: | ||
| | | | ||
| | | | ||
− | | | + | |N05AH04 |
− | |[[ | + | |[[Quetiapine]] |
|- | |- | ||
| | | | ||
שורה 29,575: | שורה 30,226: | ||
| | | | ||
| | | | ||
− | | | + | |N05AH05 |
− | |[[ | + | |[[Asenapine]] |
|- | |- | ||
| | | | ||
שורה 29,582: | שורה 30,233: | ||
| | | | ||
| | | | ||
− | | | + | |N05AH06 |
− | |[[ | + | |[[Clotiapine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N05AL |
− | | | + | | |
− | |[[ | + | |[[Benzamides]] |
|- | |- | ||
| | | | ||
שורה 29,596: | שורה 30,247: | ||
| | | | ||
| | | | ||
− | | | + | |N05AL01 |
− | | [[ | + | | [[Sulpiride]] |
|- | |- | ||
| | | | ||
שורה 29,603: | שורה 30,254: | ||
| | | | ||
| | | | ||
− | | | + | |N05AL02 |
− | |[[ | + | |[[Sultopride]] |
|- | |- | ||
| | | | ||
שורה 29,610: | שורה 30,261: | ||
| | | | ||
| | | | ||
− | | | + | |N05AL03 |
− | |[[ | + | |[[Tiapride]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N05AL04 |
− | |[[ | + | |[[Remoxipride]] |
|- | |- | ||
| | | | ||
שורה 29,624: | שורה 30,275: | ||
| | | | ||
| | | | ||
− | | | + | |N05AL05 |
− | |[[ | + | |[[Amisulpride]] |
|- | |- | ||
| | | | ||
שורה 29,631: | שורה 30,282: | ||
| | | | ||
| | | | ||
− | | | + | |N05AL06 |
− | |[[ | + | |[[Veralipride]] |
|- | |- | ||
| | | | ||
שורה 29,638: | שורה 30,289: | ||
| | | | ||
| | | | ||
− | | | + | |N05AL07 |
− | |[[ | + | |[[Levosulpiride]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N05AN |
− | | | + | | |
− | |[[ | + | |[[Lithium]] |
|- | |- | ||
| | | | ||
שורה 29,652: | שורה 30,303: | ||
| | | | ||
| | | | ||
− | | | + | |N05AN01 |
− | |[[ | + | |[[Lithium]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N05AX |
| | | | ||
− | |[[ | + | |[[Other antipsychotics]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | | N05AX07 |
− | |[[ | + | |[[Prothipendyl]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N05AX08 |
− | |[[ | + | |[[Risperidone]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N05AX10 |
− | | [[ | + | |[[Mosapramine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N05AX11 |
− | | [[ | + | |[[Zotepine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N05AX12 |
− | | [[ | + | |[[Aripiprazole]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N05AX13 |
+ | |[[Paliperidone]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N05AX14 |
− | |[[ | + | |[[Iloperidone]] |
|- | |- | ||
| | | | ||
| | | | ||
+ | |N05B | ||
| | | | ||
− | | | + | | |
− | + | | [[Anxiolytics]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N05BA |
− | | | + | | |
− | | [[ | + | |[[Benzodiazepine derivatives]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N05BA01 |
+ | |[[Diazepam]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N05BA02 |
− | | [[ | + | |[[Chlordiazepoxide]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N05BA03 |
− | |[[ | + | |[[Medazepam]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N05BA04 |
− | |[[ | + | |[[Oxazepam]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N05BA05 |
− | |[[ | + | |[[Potassium clorazepate]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N05BA06 |
− | |[[ | + | |[[Lorazepam]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N05BA07 |
− | |[[ | + | |[[Adinazolam]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N05BA08 |
+ | |[[Bromazepam]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N05BA09 |
− | | [[ | + | |[[Clobazam]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N05BA10 |
− | |[[ | + | |[[Ketazolam]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
− | |||
− | |||
− | |||
| | | | ||
+ | |N05BA11 | ||
+ | |[[Prazepam]] | ||
+ | |- | ||
| | | | ||
| | | | ||
− | |||
− | |||
− | |||
− | |||
| | | | ||
| | | | ||
+ | |N05BA12 | ||
+ | |[[Alprazolam]] | ||
+ | |- | ||
| | | | ||
− | |||
− | |||
− | |||
− | |||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N05BA13 |
− | + | |[[Halazepam]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N05BA14 |
− | |[[ | + | |[[Pinazepam]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N05BA15 |
+ | |[[Camazepam]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |N05BA16 |
− | |[[ | + | | [[Nordazepam]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N05BA17 |
+ | |[[Fludiazepam]] | ||
|- | |- | ||
| | | | ||
שורה 29,855: | שורה 30,499: | ||
| | | | ||
| | | | ||
− | | | + | |N05BA18 |
− | |[[ | + | |[[Ethyl loflazepate]] |
|- | |- | ||
| | | | ||
שורה 29,862: | שורה 30,506: | ||
| | | | ||
| | | | ||
− | | | + | |N05BA19 |
− | |[[ | + | |[[Etizolam]] |
|- | |- | ||
| | | | ||
שורה 29,869: | שורה 30,513: | ||
| | | | ||
| | | | ||
− | | | + | |N05BA21 |
− | |[[ | + | |[[Clotiazepam]] |
|- | |- | ||
| | | | ||
שורה 29,876: | שורה 30,520: | ||
| | | | ||
| | | | ||
− | | | + | |N05BA22 |
− | |[[ | + | |[[Cloxazolam]] |
|- | |- | ||
| | | | ||
שורה 29,883: | שורה 30,527: | ||
| | | | ||
| | | | ||
− | | | + | |N05BA23 |
− | |[[ | + | |[[Tofisopam]] |
|- | |- | ||
| | | | ||
שורה 29,890: | שורה 30,534: | ||
| | | | ||
| | | | ||
− | | | + | |N05BA56 |
− | |[[ | + | |[[Lorazepam, combinations]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N05BB | ||
| | | | ||
− | + | |[[Diphenylmethane derivatives]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | | [[ | + | |N05BB01 |
+ | | [[Hydroxyzine]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N05BB02 |
+ | |[[Captodiame]] | ||
|- | |- | ||
| | | | ||
שורה 29,918: | שורה 30,562: | ||
| | | | ||
| | | | ||
− | | | + | |N05BB51 |
− | |[[ | + | |[[Hydroxyzine, combinations]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N05BC | ||
| | | | ||
− | + | |[[Carbamates]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 29,932: | שורה 30,576: | ||
| | | | ||
| | | | ||
− | | | + | |N05BC01 |
− | |[[ | + | |[[Meprobamate]] |
|- | |- | ||
| | | | ||
שורה 29,939: | שורה 30,583: | ||
| | | | ||
| | | | ||
− | | | + | |N05BC03 |
− | |[[ | + | |[[Emylcamate]] |
|- | |- | ||
| | | | ||
שורה 29,946: | שורה 30,590: | ||
| | | | ||
| | | | ||
− | | | + | |N05BC04 |
− | |[[ | + | | [[Mebutamate]] |
|- | |- | ||
| | | | ||
שורה 29,953: | שורה 30,597: | ||
| | | | ||
| | | | ||
− | | | + | |N05BC51 |
− | |[[ | + | |[[Meprobamate, combinations]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N05BD | ||
| | | | ||
− | + | |[[Dibenzo-bicyclo-octadiene derivatives]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 29,967: | שורה 30,611: | ||
| | | | ||
| | | | ||
− | | | + | |N05BD01 |
− | |[[ | + | |[[Benzoctamine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N05BE | ||
| | | | ||
− | + | |[[Azaspirodecanedione derivatives]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 29,981: | שורה 30,625: | ||
| | | | ||
| | | | ||
− | | | + | |N05BE01 |
− | |[[ | + | |[[Buspirone]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N05BX | ||
| | | | ||
− | + | |[[Other anxiolytics]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 29,995: | שורה 30,639: | ||
| | | | ||
| | | | ||
− | | | + | |N05BX01 |
− | |[[ | + | |[[Mephenoxalone]] |
|- | |- | ||
| | | | ||
שורה 30,002: | שורה 30,646: | ||
| | | | ||
| | | | ||
− | | | + | |N05BX02 |
− | |[[ | + | | [[Gedocarnil]] |
|- | |- | ||
| | | | ||
שורה 30,009: | שורה 30,653: | ||
| | | | ||
| | | | ||
− | | | + | |N05BX03 |
− | |[[ | + | | [[Etifoxine]] |
|- | |- | ||
| | | | ||
| | | | ||
+ | |N05C | ||
| | | | ||
| | | | ||
− | + | | [[Hypnotics and sedatives]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N05CA | ||
| | | | ||
− | + | |[[Barbiturates, plain]] | |
− | | [[ | ||
|- | |- | ||
| | | | ||
שורה 30,030: | שורה 30,674: | ||
| | | | ||
| | | | ||
− | | | + | |N05CA01 |
− | |[[ | + | |[[Pentobarbital]] |
|- | |- | ||
| | | | ||
שורה 30,037: | שורה 30,681: | ||
| | | | ||
| | | | ||
− | | | + | |N05CA02 |
− | |[[ | + | |[[Amobarbital]] |
|- | |- | ||
| | | | ||
שורה 30,044: | שורה 30,688: | ||
| | | | ||
| | | | ||
− | | | + | |N05CA03 |
− | |[[ | + | | [[Butobarbital]] |
|- | |- | ||
| | | | ||
שורה 30,051: | שורה 30,695: | ||
| | | | ||
| | | | ||
− | | | + | |N05CA04 |
− | |[[ | + | |[[Barbital]] |
|- | |- | ||
| | | | ||
שורה 30,058: | שורה 30,702: | ||
| | | | ||
| | | | ||
− | | | + | |N05CA05 |
− | |[[ | + | | [[Aprobarbital]] |
|- | |- | ||
| | | | ||
שורה 30,065: | שורה 30,709: | ||
| | | | ||
| | | | ||
− | | | + | |N05CA06 |
− | |[[ | + | |[[Secobarbital]] |
|- | |- | ||
| | | | ||
שורה 30,072: | שורה 30,716: | ||
| | | | ||
| | | | ||
− | | | + | |N05CA07 |
− | |[[ | + | |[[Talbutal]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N05CA08 |
+ | |[[Vinylbital]] | ||
|- | |- | ||
| | | | ||
שורה 30,086: | שורה 30,730: | ||
| | | | ||
| | | | ||
− | | | + | |N05CA09 |
− | | [[ | + | |[[Vinbarbital]] |
|- | |- | ||
| | | | ||
שורה 30,093: | שורה 30,737: | ||
| | | | ||
| | | | ||
− | | | + | |N05CA10 |
− | |[[ | + | |[[Cyclobarbital]] |
|- | |- | ||
| | | | ||
שורה 30,100: | שורה 30,744: | ||
| | | | ||
| | | | ||
− | | | + | |N05CA11 |
− | |[[ | + | | [[Heptabarbital]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N05CA12 |
+ | | [[Reposal]] | ||
|- | |- | ||
| | | | ||
שורה 30,114: | שורה 30,758: | ||
| | | | ||
| | | | ||
− | | | + | |N05CA15 |
− | |[[ | + | | [[Methohexital]] |
|- | |- | ||
| | | | ||
שורה 30,121: | שורה 30,765: | ||
| | | | ||
| | | | ||
− | | | + | |N05CA16 |
− | |[[ | + | |[[Hexobarbital]] |
|- | |- | ||
| | | | ||
שורה 30,128: | שורה 30,772: | ||
| | | | ||
| | | | ||
− | | | + | |N05CA19 |
− | | [[ | + | |[[Thiopental]] |
|- | |- | ||
| | | | ||
שורה 30,135: | שורה 30,779: | ||
| | | | ||
| | | | ||
− | | | + | |N05CA20 |
− | |[[ | + | |[[Ethallobarbital]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N05CA21 |
+ | | [[Allobarbital]] | ||
|- | |- | ||
| | | | ||
שורה 30,149: | שורה 30,793: | ||
| | | | ||
| | | | ||
− | | | + | |N05CA22 |
− | |[[ | + | | [[Proxibarbal]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N05CB |
| | | | ||
− | |[[ | + | |[[Barbiturates, combinations]] |
|- | |- | ||
| | | | ||
שורה 30,163: | שורה 30,807: | ||
| | | | ||
| | | | ||
− | | | + | |N05CB01 |
− | |[[ | + | |[[Combinations of barbiturates]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N05CB02 |
+ | |[[Barbiturates in combination with other drugs]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N05CC | ||
| | | | ||
− | + | |[[Aldehydes and derivatives]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 30,184: | שורה 30,828: | ||
| | | | ||
| | | | ||
− | | | + | |N05CC01 |
− | | [[ | + | |[[Chloral hydrate]] |
|- | |- | ||
| | | | ||
שורה 30,191: | שורה 30,835: | ||
| | | | ||
| | | | ||
− | | | + | |N05CC02 |
− | | [[ | + | | [[Chloralodol]] |
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | | [[ | + | |N05CC03 |
+ | |[[Acetylglycinamide chloral hydrate]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N05CC04 |
+ | |[[Dichloralphenazone]] | ||
|- | |- | ||
| | | | ||
שורה 30,212: | שורה 30,856: | ||
| | | | ||
| | | | ||
− | | | + | |N05CC05 |
− | |[[ | + | |[[Paraldehyde]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N05CD | ||
| | | | ||
− | + | |[[Benzodiazepine derivatives]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 30,226: | שורה 30,870: | ||
| | | | ||
| | | | ||
− | | | + | |N05CD01 |
− | | [[ | + | |[[Flurazepam]] |
|- | |- | ||
| | | | ||
שורה 30,233: | שורה 30,877: | ||
| | | | ||
| | | | ||
− | | | + | |N05CD02 |
− | |[[ | + | |[[Nitrazepam]] |
|- | |- | ||
| | | | ||
שורה 30,240: | שורה 30,884: | ||
| | | | ||
| | | | ||
− | | | + | |N05CD03 |
− | | [[ | + | |[[Flunitrazepam]] |
|- | |- | ||
| | | | ||
שורה 30,247: | שורה 30,891: | ||
| | | | ||
| | | | ||
− | | | + | |N05CD04 |
− | |[[ | + | |[[Estazolam]] |
|- | |- | ||
| | | | ||
שורה 30,254: | שורה 30,898: | ||
| | | | ||
| | | | ||
− | | | + | |N05CD05 |
− | |[[ | + | |[[Triazolam]] |
|- | |- | ||
| | | | ||
שורה 30,261: | שורה 30,905: | ||
| | | | ||
| | | | ||
− | | | + | |N05CD06 |
− | |[[ | + | |[[Lormetazepam]] |
|- | |- | ||
| | | | ||
שורה 30,268: | שורה 30,912: | ||
| | | | ||
| | | | ||
− | | | + | |N05CD07 |
− | |[[ | + | |[[Temazepam]] |
|- | |- | ||
| | | | ||
שורה 30,275: | שורה 30,919: | ||
| | | | ||
| | | | ||
− | | | + | |N05CD08 |
− | |[[ | + | | [[Midazolam]] |
|- | |- | ||
| | | | ||
שורה 30,282: | שורה 30,926: | ||
| | | | ||
| | | | ||
− | | | + | |N05CD09 |
− | | [[ | + | |[[Brotizolam]] |
|- | |- | ||
| | | | ||
שורה 30,289: | שורה 30,933: | ||
| | | | ||
| | | | ||
− | | | + | |N05CD10 |
− | | [[ | + | |[[Quazepam]] |
|- | |- | ||
| | | | ||
שורה 30,296: | שורה 30,940: | ||
| | | | ||
| | | | ||
− | | | + | |N05CD11 |
− | | [[ | + | |[[Loprazolam]] |
|- | |- | ||
| | | | ||
שורה 30,303: | שורה 30,947: | ||
| | | | ||
| | | | ||
− | | | + | |N05CD12 |
− | |[[ | + | |[[Doxefazepam]] |
|- | |- | ||
| | | | ||
שורה 30,310: | שורה 30,954: | ||
| | | | ||
| | | | ||
− | | | + | |N05CD13 |
− | |[[ | + | |[[Cinolazepam]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N05CE | ||
| | | | ||
− | + | |[[Piperidinedione derivatives]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 30,324: | שורה 30,968: | ||
| | | | ||
| | | | ||
− | | | + | |N05CE01 |
− | | [[ | + | |[[Glutethimide]] |
|- | |- | ||
| | | | ||
שורה 30,331: | שורה 30,975: | ||
| | | | ||
| | | | ||
− | | | + | |N05CE02 |
− | | [[ | + | |[[Methyprylon]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N05CE03 |
+ | |[[Pyrithyldione]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N05CF | ||
| | | | ||
− | + | |[[Benzodiazepine related drugs]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 30,352: | שורה 30,996: | ||
| | | | ||
| | | | ||
− | | | + | |N05CF01 |
− | |[[ | + | |[[Zopiclone]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N05CF02 |
+ | | [[Zolpidem]] | ||
|- | |- | ||
| | | | ||
שורה 30,366: | שורה 31,010: | ||
| | | | ||
| | | | ||
− | | | + | |N05CF03 |
− | |[[ | + | |[[Zaleplon]] |
|- | |- | ||
| | | | ||
שורה 30,373: | שורה 31,017: | ||
| | | | ||
| | | | ||
− | | | + | |N05CF04 |
− | | [[ | + | |[[Eszopiclone]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N05CH | ||
| | | | ||
− | + | | [[Melatonin receptor agonists]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 30,387: | שורה 31,031: | ||
| | | | ||
| | | | ||
− | | | + | |N05CH01 |
− | |[[ | + | |[[Melatonin]] |
|- | |- | ||
| | | | ||
שורה 30,394: | שורה 31,038: | ||
| | | | ||
| | | | ||
− | | | + | |N05CH02 |
− | |[[ | + | |[[Ramelteon]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N05CM |
| | | | ||
− | |[[ | + | |[[Other hypnotics and sedatives]] |
|- | |- | ||
| | | | ||
שורה 30,408: | שורה 31,052: | ||
| | | | ||
| | | | ||
− | | | + | |N05CM01 |
− | |[[ | + | |[[Methaqualone]] |
|- | |- | ||
| | | | ||
שורה 30,415: | שורה 31,059: | ||
| | | | ||
| | | | ||
− | | | + | |N05CM02 |
− | |[[ | + | |[[Clomethiazole]] |
|- | |- | ||
| | | | ||
שורה 30,422: | שורה 31,066: | ||
| | | | ||
| | | | ||
− | | | + | |N05CM03 |
− | |[[ | + | |[[Bromisoval]] |
|- | |- | ||
| | | | ||
שורה 30,429: | שורה 31,073: | ||
| | | | ||
| | | | ||
− | | | + | |N05CM04 |
− | |[[ | + | |[[Carbromal]] |
|- | |- | ||
| | | | ||
שורה 30,436: | שורה 31,080: | ||
| | | | ||
| | | | ||
− | | | + | |N05CM05 |
− | |[[ | + | |[[Scopolamine]] |
|- | |- | ||
| | | | ||
שורה 30,443: | שורה 31,087: | ||
| | | | ||
| | | | ||
− | | | + | |N05CM06 |
− | |[[ | + | |[[Propiomazine]] |
|- | |- | ||
| | | | ||
שורה 30,450: | שורה 31,094: | ||
| | | | ||
| | | | ||
− | | | + | |N05CM07 |
− | |[[ | + | |[[Triclofos]] |
|- | |- | ||
| | | | ||
שורה 30,457: | שורה 31,101: | ||
| | | | ||
| | | | ||
− | | | + | |N05CM08 |
− | | [[ | + | | [[Ethchlorvynol]] |
|- | |- | ||
| | | | ||
שורה 30,464: | שורה 31,108: | ||
| | | | ||
| | | | ||
− | | | + | |N05CM09 |
− | |[[ | + | |[[Valerianae radix]] |
|- | |- | ||
| | | | ||
שורה 30,471: | שורה 31,115: | ||
| | | | ||
| | | | ||
− | | | + | |N05CM10 |
− | |[[ | + | |[[Hexapropymate]] |
|- | |- | ||
| | | | ||
שורה 30,478: | שורה 31,122: | ||
| | | | ||
| | | | ||
− | | | + | |N05CM11 |
− | |[[ | + | |[[Bromides]] |
|- | |- | ||
| | | | ||
שורה 30,485: | שורה 31,129: | ||
| | | | ||
| | | | ||
− | | | + | |N05CM12 |
− | |[[ | + | |[[Apronal]] |
|- | |- | ||
| | | | ||
שורה 30,492: | שורה 31,136: | ||
| | | | ||
| | | | ||
− | | | + | |N05CM13 |
− | |[[ | + | |[[Valnoctamide]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N05CM15 |
+ | |[[Methylpentynol]] | ||
|- | |- | ||
| | | | ||
שורה 30,506: | שורה 31,150: | ||
| | | | ||
| | | | ||
− | | | + | |N05CM16 |
− | |[[ | + | |[[Niaprazine]] |
|- | |- | ||
| | | | ||
שורה 30,513: | שורה 31,157: | ||
| | | | ||
| | | | ||
− | | | + | |N05CM18 |
− | |[[ | + | |[[Dexmedetomidine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N05CX | ||
| | | | ||
− | + | |[[Hypnotics and sedatives in combination, excluding barbiturates]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N05CX01 |
+ | |[[Meprobamate, combinations]] | ||
|- | |- | ||
| | | | ||
שורה 30,534: | שורה 31,178: | ||
| | | | ||
| | | | ||
− | | | + | |N05CX02 |
− | |[[ | + | |[[Methaqualone, combinations]] |
|- | |- | ||
| | | | ||
שורה 30,541: | שורה 31,185: | ||
| | | | ||
| | | | ||
− | | | + | |N05CX03 |
− | | [[ | + | |[[Methylpentynol, combinations]] |
|- | |- | ||
| | | | ||
שורה 30,548: | שורה 31,192: | ||
| | | | ||
| | | | ||
− | | | + | |N05CX04 |
− | |[[ | + | |[[Clomethiazole, combinations]] |
|- | |- | ||
| | | | ||
שורה 30,555: | שורה 31,199: | ||
| | | | ||
| | | | ||
− | | | + | |N05CX05 |
− | |[[ | + | |[[Emepronium, combinations]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | | [[ | + | |N05CX06 |
+ | |[[Dipiperonylaminoethanol, combinations]] | ||
|- | |- | ||
| | | | ||
+ | |N06 | ||
| | | | ||
| | | | ||
| | | | ||
− | + | | [[Psychoanaleptics]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
+ | |N06A | ||
| | | | ||
| | | | ||
− | + | |[[Antidepressants]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | |N06AA |
| | | | ||
− | |[[ | + | |[[Non-selective monoamine reuptake inhibitors]] |
|- | |- | ||
| | | | ||
שורה 30,590: | שורה 31,234: | ||
| | | | ||
| | | | ||
− | | | + | |N06AA01 |
− | |[[ | + | |[[Desipramine]] |
|- | |- | ||
| | | | ||
שורה 30,597: | שורה 31,241: | ||
| | | | ||
| | | | ||
− | | | + | |N06AA02 |
− | |[[ | + | |[[Imipramine]] |
|- | |- | ||
| | | | ||
שורה 30,604: | שורה 31,248: | ||
| | | | ||
| | | | ||
− | | | + | |N06AA03 |
− | |[[ | + | |[[Imipramine oxide]] |
|- | |- | ||
| | | | ||
שורה 30,611: | שורה 31,255: | ||
| | | | ||
| | | | ||
− | | | + | |N06AA04 |
− | |[[ | + | |[[Clomipramine]] |
|- | |- | ||
| | | | ||
שורה 30,618: | שורה 31,262: | ||
| | | | ||
| | | | ||
− | | | + | |N06AA05 |
− | |[[ | + | |[[Opipramol]] |
|- | |- | ||
| | | | ||
שורה 30,625: | שורה 31,269: | ||
| | | | ||
| | | | ||
− | | | + | |N06AA06 |
− | |[[ | + | |[[Trimipramine]] |
|- | |- | ||
| | | | ||
שורה 30,632: | שורה 31,276: | ||
| | | | ||
| | | | ||
− | | | + | |N06AA07 |
− | |[[ | + | |[[Lofepramine]] |
|- | |- | ||
| | | | ||
שורה 30,639: | שורה 31,283: | ||
| | | | ||
| | | | ||
− | | | + | |N06AA08 |
− | | [[ | + | |[[Dibenzepin]] |
|- | |- | ||
| | | | ||
שורה 30,646: | שורה 31,290: | ||
| | | | ||
| | | | ||
− | | | + | |N06AA09 |
− | |[[ | + | |[[Amitriptyline]] |
|- | |- | ||
| | | | ||
שורה 30,653: | שורה 31,297: | ||
| | | | ||
| | | | ||
− | | | + | |N06AA10 |
− | |[[ | + | |[[Nortriptyline]] |
|- | |- | ||
| | | | ||
שורה 30,660: | שורה 31,304: | ||
| | | | ||
| | | | ||
− | | | + | |N06AA11 |
− | |[[ | + | |[[Protriptyline]] |
|- | |- | ||
| | | | ||
שורה 30,667: | שורה 31,311: | ||
| | | | ||
| | | | ||
− | | | + | |N06AA12 |
− | |[[ | + | |[[Doxepin]] |
|- | |- | ||
| | | | ||
שורה 30,674: | שורה 31,318: | ||
| | | | ||
| | | | ||
− | | | + | |N06AA13 |
− | |[[ | + | |[[Iprindole]] |
|- | |- | ||
| | | | ||
שורה 30,681: | שורה 31,325: | ||
| | | | ||
| | | | ||
− | | | + | |N06AA14 |
− | |[[ | + | |[[Melitracen]] |
|- | |- | ||
| | | | ||
שורה 30,688: | שורה 31,332: | ||
| | | | ||
| | | | ||
− | | | + | |N06AA15 |
− | |[[ | + | |[[Butriptyline]] |
|- | |- | ||
| | | | ||
שורה 30,695: | שורה 31,339: | ||
| | | | ||
| | | | ||
− | | | + | |N06AA16 |
− | |[[ | + | |[[Dosulepin]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N06AA17 |
+ | |[[Amoxapine]] | ||
|- | |- | ||
| | | | ||
שורה 30,709: | שורה 31,353: | ||
| | | | ||
| | | | ||
− | | | + | |N06AA18 |
− | |[[ | + | |[[Dimetacrine]] |
|- | |- | ||
| | | | ||
שורה 30,716: | שורה 31,360: | ||
| | | | ||
| | | | ||
− | | | + | |N06AA19 |
− | |[[ | + | |[[Amineptine]] |
|- | |- | ||
| | | | ||
שורה 30,723: | שורה 31,367: | ||
| | | | ||
| | | | ||
− | | | + | |N06AA21 |
− | |[[ | + | |[[Maprotiline]] |
|- | |- | ||
| | | | ||
שורה 30,730: | שורה 31,374: | ||
| | | | ||
| | | | ||
− | | | + | |N06AA23 |
− | |[[ | + | |[[Quinupramine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N06AB | ||
| | | | ||
− | + | |[[Selective serotonin reuptake inhibitors]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 30,744: | שורה 31,388: | ||
| | | | ||
| | | | ||
− | | | + | |N06AB02 |
− | |[[ | + | |[[Zimelidine]] |
|- | |- | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
| | | | ||
− | | [[ | + | |N06AB03 |
+ | |[[Fluoxetine]] | ||
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | |[[ | + | |N06AB04 |
+ | |[[Citalopram]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N06AB05 |
+ | |[[Paroxetine]] | ||
|- | |- | ||
| | | | ||
שורה 30,772: | שורה 31,416: | ||
| | | | ||
| | | | ||
− | | | + | |N06AB06 |
− | |[[ | + | |[[Sertraline]] |
|- | |- | ||
| | | | ||
שורה 30,779: | שורה 31,423: | ||
| | | | ||
| | | | ||
− | | | + | |N06AB07 |
− | |[[ | + | |[[Alaproclate]] |
|- | |- | ||
| | | | ||
שורה 30,786: | שורה 31,430: | ||
| | | | ||
| | | | ||
− | | | + | |N06AB08 |
− | |[[ | + | |[[Fluvoxamine]] |
|- | |- | ||
| | | | ||
שורה 30,793: | שורה 31,437: | ||
| | | | ||
| | | | ||
− | | | + | |N06AB09 |
− | |[[ | + | |[[Etoperidone]] |
|- | |- | ||
| | | | ||
שורה 30,800: | שורה 31,444: | ||
| | | | ||
| | | | ||
− | | | + | |N06AB10 |
− | |[[ | + | |[[Escitalopram]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N06AF | ||
| | | | ||
− | + | |[[Monoamine oxidase inhibitors, non-selective]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 30,814: | שורה 31,458: | ||
| | | | ||
| | | | ||
− | | | + | |N06AF01 |
− | |[[ | + | |[[Isocarboxazid]] |
|- | |- | ||
| | | | ||
שורה 30,821: | שורה 31,465: | ||
| | | | ||
| | | | ||
− | | | + | |N06AF02 |
− | |[[ | + | |[[Nialamide]] |
|- | |- | ||
| | | | ||
שורה 30,828: | שורה 31,472: | ||
| | | | ||
| | | | ||
− | | | + | |N06AF03 |
− | |[[ | + | |[[Phenelzine]] |
|- | |- | ||
| | | | ||
שורה 30,835: | שורה 31,479: | ||
| | | | ||
| | | | ||
− | | | + | |N06AF04 |
− | |[[ | + | |[[Tranylcypromine]] |
|- | |- | ||
| | | | ||
שורה 30,842: | שורה 31,486: | ||
| | | | ||
| | | | ||
− | | | + | |N06AF05 |
− | |[[ | + | |[[Iproniazide]] |
|- | |- | ||
| | | | ||
שורה 30,849: | שורה 31,493: | ||
| | | | ||
| | | | ||
− | | | + | |N06AF06 |
− | |[[ | + | |[[Iproclozide]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N06AG | ||
| | | | ||
− | + | | [[Monoamine oxidase A inhibitors]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 30,863: | שורה 31,507: | ||
| | | | ||
| | | | ||
− | | | + | |N06AG02 |
− | |[[ | + | |[[Moclobemide]] |
|- | |- | ||
| | | | ||
שורה 30,870: | שורה 31,514: | ||
| | | | ||
| | | | ||
− | | | + | |N06AG03 |
− | |[[ | + | |[[Toloxatone]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N06AX | ||
| | | | ||
− | + | |[[Other antidepressants]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 30,884: | שורה 31,528: | ||
| | | | ||
| | | | ||
− | | | + | |N06AX01 |
− | |[[ | + | |[[Oxitriptan]] |
|- | |- | ||
| | | | ||
שורה 30,891: | שורה 31,535: | ||
| | | | ||
| | | | ||
− | | | + | |N06AX02 |
− | |[[ | + | |[[Tryptophan]] |
|- | |- | ||
| | | | ||
שורה 30,898: | שורה 31,542: | ||
| | | | ||
| | | | ||
− | | | + | |N06AX03 |
− | |[[ | + | |[[Mianserin]] |
|- | |- | ||
| | | | ||
שורה 30,905: | שורה 31,549: | ||
| | | | ||
| | | | ||
− | | | + | |N06AX04 |
− | |[[ | + | |[[Nomifensine]] |
|- | |- | ||
| | | | ||
שורה 30,912: | שורה 31,556: | ||
| | | | ||
| | | | ||
− | | | + | |N06AX05 |
− | |[[ | + | |[[Trazodone]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N06AX06 |
+ | |[[Nefazodone]] | ||
|- | |- | ||
| | | | ||
שורה 30,926: | שורה 31,570: | ||
| | | | ||
| | | | ||
− | | | + | |N06AX07 |
− | |[[ | + | |[[Minaprine]] |
|- | |- | ||
| | | | ||
שורה 30,933: | שורה 31,577: | ||
| | | | ||
| | | | ||
− | | | + | |N06AX08 |
− | |[[ | + | |[[Bifemelane]] |
|- | |- | ||
| | | | ||
שורה 30,940: | שורה 31,584: | ||
| | | | ||
| | | | ||
− | | | + | |N06AX09 |
− | |[[ | + | |[[Viloxazine]] |
|- | |- | ||
| | | | ||
שורה 30,947: | שורה 31,591: | ||
| | | | ||
| | | | ||
− | | | + | |N06AX10 |
− | |[[ | + | |[[Oxaflozane]] |
|- | |- | ||
| | | | ||
שורה 30,954: | שורה 31,598: | ||
| | | | ||
| | | | ||
− | | | + | |N06AX11 |
− | |[[ | + | |[[Mirtazapine]] |
|- | |- | ||
| | | | ||
שורה 30,961: | שורה 31,605: | ||
| | | | ||
| | | | ||
− | | | + | |N06AX12 |
− | |[[ | + | |[[Bupropion]] |
|- | |- | ||
| | | | ||
שורה 30,968: | שורה 31,612: | ||
| | | | ||
| | | | ||
− | | | + | |N06AX13 |
− | |[[ | + | |[[Medifoxamine]] |
|- | |- | ||
| | | | ||
שורה 30,975: | שורה 31,619: | ||
| | | | ||
| | | | ||
− | | | + | |N06AX14 |
− | |[[ | + | |[[Tianeptine]] |
|- | |- | ||
| | | | ||
שורה 30,982: | שורה 31,626: | ||
| | | | ||
| | | | ||
− | | | + | |N06AX15 |
− | |[[ | + | |[[Pivagabine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N06AX16 |
+ | |[[Venlafaxine]] | ||
|- | |- | ||
| | | | ||
שורה 30,996: | שורה 31,640: | ||
| | | | ||
| | | | ||
− | | | + | |N06AX17 |
− | |[[ | + | |[[Milnacipran]] |
|- | |- | ||
| | | | ||
שורה 31,003: | שורה 31,647: | ||
| | | | ||
| | | | ||
− | | | + | |N06AX18 |
− | |[[ | + | |[[Reboxetine]] |
|- | |- | ||
| | | | ||
שורה 31,010: | שורה 31,654: | ||
| | | | ||
| | | | ||
− | | | + | |N06AX19 |
− | |[[ | + | |[[Gepirone]] |
|- | |- | ||
| | | | ||
שורה 31,017: | שורה 31,661: | ||
| | | | ||
| | | | ||
− | | | + | |N06AX21 |
− | |[[ | + | |[[Duloxetine]] |
|- | |- | ||
| | | | ||
שורה 31,024: | שורה 31,668: | ||
| | | | ||
| | | | ||
− | | | + | |N06AX22 |
− | |[[ | + | |[[Agomelatine]] |
|- | |- | ||
| | | | ||
שורה 31,031: | שורה 31,675: | ||
| | | | ||
| | | | ||
− | | | + | |N06AX23 |
− | |[[ | + | |[[Desvenlafaxine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | | [[ | + | |N06AX24 |
+ | |[[Vilazodone]] | ||
|- | |- | ||
| | | | ||
שורה 31,045: | שורה 31,689: | ||
| | | | ||
| | | | ||
− | | | + | |N06AX25 |
− | |[[ | + | |[[Hyperici herba]] |
|- | |- | ||
| | | | ||
שורה 31,052: | שורה 31,696: | ||
| | | | ||
| | | | ||
− | | | + | |N06AX26 |
− | |[[ | + | |[[Vortioxetine (proposed code)]] |
|- | |- | ||
| | | | ||
| | | | ||
+ | |N06B | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |[[Psychostimulants, agents used for ADHD and nootropics]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N06BA | ||
| | | | ||
− | + | |[[Centrally acting sympathomimetics]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 31,073: | שורה 31,717: | ||
| | | | ||
| | | | ||
− | | | + | |N06BA01 |
− | |[[ | + | |[[Amphetamine]] |
|- | |- | ||
| | | | ||
שורה 31,080: | שורה 31,724: | ||
| | | | ||
| | | | ||
− | | | + | |N06BA02 |
− | |[[ | + | |[[Dexamphetamine]] |
|- | |- | ||
| | | | ||
שורה 31,087: | שורה 31,731: | ||
| | | | ||
| | | | ||
− | | | + | |N06BA03 |
− | |[[ | + | |[[Dextromethamphetamine]] |
|- | |- | ||
| | | | ||
שורה 31,094: | שורה 31,738: | ||
| | | | ||
| | | | ||
− | | | + | |N06BA04 |
− | |[[ | + | |[[Methylphenidate]] |
|- | |- | ||
| | | | ||
שורה 31,101: | שורה 31,745: | ||
| | | | ||
| | | | ||
− | | | + | |N06BA05 |
− | |[[ | + | |[[Pemoline]] |
|- | |- | ||
| | | | ||
שורה 31,108: | שורה 31,752: | ||
| | | | ||
| | | | ||
− | | | + | |N06BA06 |
− | |[[ | + | |[[Fencamfamin]] |
|- | |- | ||
| | | | ||
שורה 31,115: | שורה 31,759: | ||
| | | | ||
| | | | ||
− | | | + | |N06BA07 |
− | |[[ | + | |[[Modafinil]] |
|- | |- | ||
| | | | ||
שורה 31,122: | שורה 31,766: | ||
| | | | ||
| | | | ||
− | | | + | |N06BA08 |
− | |[[ | + | |[[Fenozolone]] |
|- | |- | ||
| | | | ||
שורה 31,129: | שורה 31,773: | ||
| | | | ||
| | | | ||
− | | | + | |N06BA09 |
− | |[[ | + | |[[Atomoxetine]] |
|- | |- | ||
| | | | ||
שורה 31,136: | שורה 31,780: | ||
| | | | ||
| | | | ||
− | | | + | |N06BA10 |
− | |[[ | + | |[[Fenetylline]] |
|- | |- | ||
| | | | ||
שורה 31,143: | שורה 31,787: | ||
| | | | ||
| | | | ||
− | | | + | |N06BA11 |
− | |[[ | + | |[[Dexmethylphenidate]] |
|- | |- | ||
| | | | ||
שורה 31,150: | שורה 31,794: | ||
| | | | ||
| | | | ||
− | | | + | |N06BA12 |
− | |[[ | + | |[[Lisdexamfetamine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N06BC | ||
| | | | ||
− | + | |[[Xanthine derivatives]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 31,164: | שורה 31,808: | ||
| | | | ||
| | | | ||
− | | | + | |N06BC01 |
− | |[[ | + | |[[Caffeine]] |
|- | |- | ||
| | | | ||
שורה 31,171: | שורה 31,815: | ||
| | | | ||
| | | | ||
− | | | + | |N06BC02 |
− | |[[ | + | |[[Propentofylline]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N06BX | ||
| | | | ||
− | + | |[[Other psychostimulants and nootropics]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 31,185: | שורה 31,829: | ||
| | | | ||
| | | | ||
− | | | + | |N06BX01 |
− | |[[ | + | |[[Meclofenoxate]] |
|- | |- | ||
| | | | ||
שורה 31,192: | שורה 31,836: | ||
| | | | ||
| | | | ||
− | | | + | |N06BX02 |
− | |[[ | + | |[[Pyritinol]] |
|- | |- | ||
| | | | ||
שורה 31,199: | שורה 31,843: | ||
| | | | ||
| | | | ||
− | | | + | |N06BX03 |
− | |[[ | + | |[[Piracetam]] |
|- | |- | ||
| | | | ||
שורה 31,206: | שורה 31,850: | ||
| | | | ||
| | | | ||
− | | | + | |N06BX04 |
− | |[[ | + | |[[Deanol]] |
|- | |- | ||
| | | | ||
שורה 31,213: | שורה 31,857: | ||
| | | | ||
| | | | ||
− | | | + | |N06BX05 |
− | |[[ | + | |[[Fipexide]] |
|- | |- | ||
| | | | ||
שורה 31,220: | שורה 31,864: | ||
| | | | ||
| | | | ||
− | | | + | |N06BX06 |
− | |[[ | + | |[[Citicoline]] |
|- | |- | ||
| | | | ||
שורה 31,227: | שורה 31,871: | ||
| | | | ||
| | | | ||
− | | | + | |N06BX07 |
− | |[[ | + | |[[Oxiracetam]] |
|- | |- | ||
| | | | ||
שורה 31,234: | שורה 31,878: | ||
| | | | ||
| | | | ||
− | | | + | |N06BX08 |
− | |[[ | + | |[[Pirisudanol]] |
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | |[[ | + | |N06BX09 |
+ | |[[Linopirdine]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N06BX10 |
+ | |[[Nizofenone]] | ||
|- | |- | ||
| | | | ||
שורה 31,255: | שורה 31,899: | ||
| | | | ||
| | | | ||
− | | | + | |N06BX11 |
− | |[[ | + | |[[Aniracetam]] |
|- | |- | ||
| | | | ||
שורה 31,262: | שורה 31,906: | ||
| | | | ||
| | | | ||
− | | | + | |N06BX12 |
− | |[[ | + | |[[Acetylcarnitine]] |
|- | |- | ||
| | | | ||
שורה 31,269: | שורה 31,913: | ||
| | | | ||
| | | | ||
− | | | + | |N06BX13 |
− | |[[ | + | |[[Idebenone]] |
|- | |- | ||
| | | | ||
שורה 31,276: | שורה 31,920: | ||
| | | | ||
| | | | ||
− | | | + | |N06BX14 |
− | |[[ | + | |[[Prolintane]] |
|- | |- | ||
| | | | ||
שורה 31,283: | שורה 31,927: | ||
| | | | ||
| | | | ||
− | | | + | |N06BX15 |
− | |[[ | + | |[[Pipradrol]] |
|- | |- | ||
| | | | ||
שורה 31,290: | שורה 31,934: | ||
| | | | ||
| | | | ||
− | | | + | |N06BX16 |
− | |[[ | + | |[[Pramiracetam]] |
|- | |- | ||
| | | | ||
שורה 31,297: | שורה 31,941: | ||
| | | | ||
| | | | ||
− | | | + | |N06BX17 |
− | |[[ | + | |[[Adrafinil]] |
|- | |- | ||
| | | | ||
שורה 31,304: | שורה 31,948: | ||
| | | | ||
| | | | ||
− | | | + | |N06BX18 |
− | |[[ | + | |[[Vinpocetine]] |
|- | |- | ||
| | | | ||
| | | | ||
+ | |N06C | ||
| | | | ||
| | | | ||
− | + | |[[Psycholeptics and psychoanaleptics in combination]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N06CA | ||
| | | | ||
− | + | |[[Antidepressants in combination with psycholeptics]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 31,325: | שורה 31,969: | ||
| | | | ||
| | | | ||
− | | | + | |N06CA01 |
− | |[[ | + | |[[Amitriptyline and psycholeptics]] |
|- | |- | ||
| | | | ||
שורה 31,332: | שורה 31,976: | ||
| | | | ||
| | | | ||
− | | | + | |N06CA02 |
− | |[[ | + | |[[Melitracen and psycholeptics]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N06CA03 |
+ | |[[Fluoxetine and psycholeptics]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N06CB | ||
| | | | ||
− | + | |[[Psychostimulants in combination with psycholeptics]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 31,353: | שורה 31,997: | ||
| | | | ||
| | | | ||
− | | | + | | |
− | | | + | |empty |
|- | |- | ||
| | | | ||
| | | | ||
+ | |N06D | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |[[Anti-dementia drugs]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N06DA | ||
| | | | ||
− | + | |[[Anticholinesterases]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 31,374: | שורה 32,018: | ||
| | | | ||
| | | | ||
− | | | + | |N06DA01 |
− | |[[ | + | |[[Tacrine]] |
|- | |- | ||
| | | | ||
שורה 31,381: | שורה 32,025: | ||
| | | | ||
| | | | ||
− | | | + | |N06DA02 |
− | |[[ | + | |[[Donepezil]] |
|- | |- | ||
| | | | ||
שורה 31,388: | שורה 32,032: | ||
| | | | ||
| | | | ||
− | | | + | |N06DA03 |
− | |[[ | + | |[[Rivastigmine]] |
|- | |- | ||
| | | | ||
שורה 31,395: | שורה 32,039: | ||
| | | | ||
| | | | ||
− | | | + | |N06DA04 |
− | |[[ | + | |[[Galantamine]] |
|- | |- | ||
| | | | ||
שורה 31,402: | שורה 32,046: | ||
| | | | ||
| | | | ||
− | | | + | |N06DA52 |
− | |[[ | + | |[[Donepezil and memantine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N06DX | ||
| | | | ||
− | + | |[[Other anti-dementia drugs]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 31,416: | שורה 32,060: | ||
| | | | ||
| | | | ||
− | | | + | |N06DX01 |
− | |[[ | + | |[[Memantine]] |
|- | |- | ||
| | | | ||
שורה 31,423: | שורה 32,067: | ||
| | | | ||
| | | | ||
− | | | + | |N06DX02 |
− | |[[ | + | |[[Ginkgo folium]] |
|- | |- | ||
| | | | ||
+ | |N07 | ||
| | | | ||
| | | | ||
| | | | ||
− | + | | [[Other nervous system drugs]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
+ | | N07A | ||
| | | | ||
| | | | ||
− | + | |[[Parasympathomimetics]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | | N07AA | ||
| | | | ||
− | + | |[[Anticholinesterases]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 31,451: | שורה 32,095: | ||
| | | | ||
| | | | ||
− | | | + | |N07AA01 |
− | |[[ | + | |[[Neostigmine]] |
|- | |- | ||
| | | | ||
שורה 31,458: | שורה 32,102: | ||
| | | | ||
| | | | ||
− | | | + | |N07AA02 |
− | |[[ | + | |[[Pyridostigmine]] |
|- | |- | ||
| | | | ||
שורה 31,465: | שורה 32,109: | ||
| | | | ||
| | | | ||
− | | | + | |N07AA03 |
− | |[[ | + | |[[Distigmine]] |
|- | |- | ||
| | | | ||
שורה 31,472: | שורה 32,116: | ||
| | | | ||
| | | | ||
− | | | + | |N07AA30 |
− | |[[ | + | |[[Ambenonium]] |
|- | |- | ||
| | | | ||
שורה 31,479: | שורה 32,123: | ||
| | | | ||
| | | | ||
− | | | + | |N07AA51 |
− | |[[ | + | | [[Neostigmine, combinations]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | | N07AB | ||
| | | | ||
− | + | |[[Choline esters]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | |[[ | + | |N07AB01 |
+ | |[[Carbachol]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N07AB02 |
+ | | [[Bethanechol]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | | N07AX | ||
| | | | ||
− | + | |[[Other parasympathomimetics]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 31,514: | שורה 32,158: | ||
| | | | ||
| | | | ||
− | | | + | |N07AX01 |
− | |[[ | + | |[[Pilocarpine]] |
|- | |- | ||
| | | | ||
שורה 31,521: | שורה 32,165: | ||
| | | | ||
| | | | ||
− | | | + | |N07AX02 |
− | |[[ | + | | [[Choline alfoscerate]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N07AX03 |
+ | |[[Cevimeline]] | ||
|- | |- | ||
| | | | ||
| | | | ||
+ | | N07B | ||
| | | | ||
| | | | ||
− | | | + | |[[Drugs used in addictive disorders]] |
− | |||
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
+ | | N07BA | ||
| | | | ||
− | |[[ | + | |[[Drugs used in nicotine dependence]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N07BA01 |
+ | |[[Nicotine]] | ||
|- | |- | ||
| | | | ||
שורה 31,556: | שורה 32,200: | ||
| | | | ||
| | | | ||
− | | | + | |N07BA03 |
− | |[[ | + | |[[Varenicline]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N07BB | ||
| | | | ||
− | + | |[[Drugs used in alcohol dependence]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 31,570: | שורה 32,214: | ||
| | | | ||
| | | | ||
− | | | + | |N07BB01 |
− | |[[ | + | |[[Disulfiram]] |
|- | |- | ||
| | | | ||
שורה 31,577: | שורה 32,221: | ||
| | | | ||
| | | | ||
− | | | + | |N07BB02 |
− | |[[ | + | |[[Calcium carbimide]] |
|- | |- | ||
| | | | ||
שורה 31,584: | שורה 32,228: | ||
| | | | ||
| | | | ||
− | | | + | |N07BB03 |
− | |[[ | + | |[[Acamprosate]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N07BB04 |
+ | |[[Naltrexone]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N07BC | ||
| | | | ||
− | + | |[[Drugs used in opioid dependence]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 31,605: | שורה 32,249: | ||
| | | | ||
| | | | ||
− | | | + | |N07BC01 |
− | |[[ | + | | [[Buprenorphine]] |
|- | |- | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
| | | | ||
− | | [[ | + | |N07BC02 |
+ | | [[Methadone]] | ||
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | |[[ | + | |N07BC03 |
+ | |[[Levacetylmethadol]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N07BC04 |
+ | | [[Lofexidine]] | ||
|- | |- | ||
| | | | ||
שורה 31,633: | שורה 32,277: | ||
| | | | ||
| | | | ||
− | | | + | |N07BC05 |
− | |[[ | + | |[[Levomethadone]] |
|- | |- | ||
| | | | ||
שורה 31,640: | שורה 32,284: | ||
| | | | ||
| | | | ||
− | | | + | |N07BC06 |
− | |[[ | + | | [[Diamorphine]] |
|- | |- | ||
| | | | ||
שורה 31,647: | שורה 32,291: | ||
| | | | ||
| | | | ||
− | | | + | |N07BC51 |
− | |[[ | + | |[[Buprenorphine, combinations]] |
|- | |- | ||
| | | | ||
| | | | ||
+ | |N07C | ||
| | | | ||
| | | | ||
− | + | |[[Antivertigo preparations]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N07CA | ||
| | | | ||
− | + | |[[Antivertigo preparations]] | |
− | | [[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N07CA01 |
+ | |[[Betahistine]] | ||
|- | |- | ||
| | | | ||
שורה 31,675: | שורה 32,319: | ||
| | | | ||
| | | | ||
− | | | + | |N07CA02 |
− | |[[ | + | |[[Cinnarizine]] |
|- | |- | ||
| | | | ||
שורה 31,682: | שורה 32,326: | ||
| | | | ||
| | | | ||
− | | | + | |N07CA03 |
− | | [[ | + | | [[Flunarizine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N07CA04 |
+ | | [[Acetylleucine]] | ||
|- | |- | ||
| | | | ||
שורה 31,696: | שורה 32,340: | ||
| | | | ||
| | | | ||
− | | | + | |N07CA52 |
− | |[[ | + | |[[Cinnarizine, combinations]] |
|- | |- | ||
| | | | ||
| | | | ||
+ | | N07X | ||
| | | | ||
| | | | ||
− | + | |[[Other nervous system drugs]] | |
− | | [[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | |N07XA | ||
| | | | ||
− | + | |[[Gangliosides and ganglioside derivatives]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | | | + | | |
+ | |empty | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | | | + | | N07XX |
| | | | ||
− | |[[ | + | |[[Other nervous system drugs]] |
|- | |- | ||
| | | | ||
שורה 31,731: | שורה 32,375: | ||
| | | | ||
| | | | ||
− | | | + | |N07XX01 |
− | |[[ | + | | [[Tirilazad]] |
|- | |- | ||
| | | | ||
שורה 31,738: | שורה 32,382: | ||
| | | | ||
| | | | ||
− | | | + | |N07XX02 |
− | |[[ | + | |[[Riluzole]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N07XX03 |
+ | |[[Xaliproden]] | ||
|- | |- | ||
| | | | ||
שורה 31,752: | שורה 32,396: | ||
| | | | ||
| | | | ||
− | | | + | |N07XX04 |
− | |[[ | + | | [[Sodium oxybate]] |
|- | |- | ||
| | | | ||
שורה 31,759: | שורה 32,403: | ||
| | | | ||
| | | | ||
− | | | + | |N07XX05 |
− | |[[ | + | |[[Amifampridine]] |
|- | |- | ||
| | | | ||
שורה 31,766: | שורה 32,410: | ||
| | | | ||
| | | | ||
− | | | + | |N07XX06 |
− | |[[ | + | |[[Tetrabenazine]] |
|- | |- | ||
| | | | ||
שורה 31,773: | שורה 32,417: | ||
| | | | ||
| | | | ||
− | | | + | |N07XX07 |
− | |[[ | + | | [[Fampridine]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |N07XX08 |
+ | |[[Tafamidis]] | ||
|- | |- | ||
| | | | ||
שורה 31,787: | שורה 32,431: | ||
| | | | ||
| | | | ||
− | | | + | |N07XX10 |
− | | [[ | + | |[[laquinimod ]] |
|- | |- | ||
| | | | ||
שורה 31,794: | שורה 32,438: | ||
| | | | ||
| | | | ||
− | | | + | |N07XX11 |
− | | [[ | + | |[[pitolisant ]] |
|- | |- | ||
| | | | ||
שורה 31,801: | שורה 32,445: | ||
| | | | ||
| | | | ||
− | | | + | |N07XX12 |
− | |[[ | + | |[[patisiran ]] |
|- | |- | ||
| | | | ||
שורה 31,808: | שורה 32,452: | ||
| | | | ||
| | | | ||
− | | | + | |N07XX13 |
− | | [[ | + | |[[valbenazine]] |
|- | |- | ||
| | | | ||
שורה 31,815: | שורה 32,459: | ||
| | | | ||
| | | | ||
− | | | + | |N07XX14 |
− | |[[ | + | |[[edaravone]] |
|- | |- | ||
| | | | ||
שורה 31,822: | שורה 32,466: | ||
| | | | ||
| | | | ||
− | | | + | |N07XX15 |
− | | [[ | + | |[[inotersen]] |
|- | |- | ||
| | | | ||
שורה 31,829: | שורה 32,473: | ||
| | | | ||
| | | | ||
− | | | + | |N07XX59 |
− | |[[ | + | |[[Dextromethorphan, combinations]] |
|- | |- | ||
+ | |{{עוגן2|עוגןP}}{{כ}}P | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | |[[ | + | |[[Antiparasitic products, insecticides and repellents]] |
|- | |- | ||
| | | | ||
+ | |P01 | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |[[Antiprotozoals]] |
|- | |- | ||
| | | | ||
| | | | ||
+ | | P01A | ||
| | | | ||
| | | | ||
− | + | |[[Agents against amoebiasis and other protozoal diseases]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | | P01AA | ||
| | | | ||
− | + | |[[Hydroxyquinoline derivatives]] | |
− | |[[ | ||
|- | |- | ||
| | | | ||
שורה 31,864: | שורה 32,508: | ||
| | | | ||
| | | | ||
− | | | + | |P01AA01 |
− | | [[ | + | |[[Broxyquinoline]] |
|- | |- | ||
| | | | ||
שורה 31,871: | שורה 32,515: | ||
| | | | ||
| | | | ||
− | | | + | |P01AA02 |
− | | [[ | + | |[[Clioquinol]] |
|- | |- | ||
| | | | ||
שורה 31,878: | שורה 32,522: | ||
| | | | ||
| | | | ||
− | | | + | ||P01AA04 |
− | |[[ | + | |[[Chlorquinaldol]] |
|- | |- | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
| | | | ||
− | |[[ | + | |P01AA05 |
+ | |[[Tilbroquinol]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |P01AA52 |
+ | |[[Clioquinol, combinations]] | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | | P01AB | ||
| | | | ||
− | | | + | |[[Nitroimidazole derivatives]] |
− | |||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
− | |||
| | | | ||
− | |[[ | + | |P01AB01 |
+ | |[[Metronidazole]] | ||
|- | |- | ||
| | | | ||
שורה 31,913: | שורה 32,557: | ||
| | | | ||
| | | | ||
− | | | + | |P01AB02 |
− | | [[ | + | | [[Tinidazole]] |
|- | |- | ||
| | | | ||
שורה 31,920: | שורה 32,564: | ||
| | | | ||
| | | | ||
− | | | + | |P01AB03 |
− | |[[ | + | | [[Ornidazole]] |
|- | |- | ||
| | | | ||
שורה 31,927: | שורה 32,571: | ||
| | | | ||
| | | | ||
− | | | + | |P01AB04 |
− | |[[ | + | |[[Azanidazole]] |
|- | |- | ||
| | | | ||
שורה 31,934: | שורה 32,578: | ||
| | | | ||
| | | | ||
− | | | + | |P01AB05 |
− | | [[ | + | | [[Propenidazole]] |
|- | |- | ||
| | | | ||
שורה 31,941: | שורה 32,585: | ||
| | | | ||
| | | | ||
− | | | + | |P01AB06 |
− | |[[ | + | | [[Nimorazole]] |
|- | |- | ||
| | | | ||
שורה 31,948: | שורה 32,592: | ||
| | | | ||
| | | | ||
− | | | + | |P01AB07 |
− | |[[ | + | |[[Secnidazole]] |
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
+ | | P01AC | ||
| | | | ||
− | + | |[[Dichloroacetamide derivatives]] | |
− | | [[ | ||
|- | |- | ||
| | | | ||
שורה 31,962: | שורה 32,606: | ||
| | | | ||
| | | | ||
− | | | + | |P01AC01 |
− | |[[ | + | |[[Diloxanide]] |
|- | |- | ||
| | | | ||
שורה 31,969: | שורה 32,613: | ||
| | | | ||
| | | | ||
− | + | |P01AC02 | |
− | + | |[[Clefamide]] | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |P01AC02 | ||
− | |[[Clefamide]] | ||
|- | |- | ||
| | | | ||
שורה 34,113: | שורה 34,617: | ||
|R03AK07 | |R03AK07 | ||
|[[Formoterol and other drugs for obstructive airway diseases]] | |[[Formoterol and other drugs for obstructive airway diseases]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |R03AL | ||
+ | | | ||
+ | |[[Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |R03AL01 | ||
+ | |[[fenoterol and ipratropium bromide]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |R03AL02 | ||
+ | |[[salbutamol and ipratropium bromide]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |R03AL03 | ||
+ | |[[vilanterol and umeclidinium bromide]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |R03AL04 | ||
+ | |[[indacaterol and glycopyrronium bromide]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |R03AL05 | ||
+ | |[[formoterol and aclidinium bromide]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |R03AL06 | ||
+ | |[[olodaterol and tiotropium bromide]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |R03AL07 | ||
+ | |[[formoterol and glycopyrronium bromide]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |R03AL08 | ||
+ | |[[vilanterol, umeclidinium bromide and fluticasone furoate]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |R03AL09 | ||
+ | |[[formoterol, glycopyrronium bromide and beclometasone]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |R03AL10 | ||
+ | |[[formoterol and tiotropium bromide]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |R03AL11 | ||
+ | |[[formoterol, glycopyrronium bromide and budesonide]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |R03AL12 | ||
+ | |[[indacaterol, glycopyrronium bromide and mometasone]] | ||
|- | |- | ||
| | | |
גרסה מ־09:16, 18 ביוני 2021
מפתח קודי ATC
Anatomical Therapeutic Chemical (ATC) Classification System
מפתח זה לא כולל מוצרים וטרינריים המסווגים תחת סיווג ATCvet (Anatomical Therapeutic Chemical Classification System for veterinary medicinal products)
גישה מהירה A / B / C / D / G / H / J / L / M / N / P / R / S / V
- הטבלא ניתנת למיון לפי כל אחת מהעמודות